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RISK FACTORS FOR SURGICAL SITE INFECTION OVER TIME
Abstract
This study was designed to identify risk factors of SSI over time. We identified several surgeries
that were significant for SSI and have changed over time. Obesity was a factor of specific interest. Due
to potential under-coding this was a predictive factor, however not as significant as initially anticipated.
We were able to identify risk factors and specific groups to concentrate further study or changes in
treatment to reduce SSI. There were significant findings over time with each specific surgery type.
Surprising were the negative correlation of Charleson Comorbidity score. In addition being black was a
protective factor for SSI. The 40-49 and 50-59 year age groups as well as white males had the highest
rates of SSI. Surgeries of particular interest were rectal, pancreatic, and other abdominal surgeries.
These surgeries had the highest risk for SSI.
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10-Year Time Trends In Patients Undergoing Abdominal Surgery: Do Surgical Site Infection Risks Change
Over Time?

Chapter 1
Introduction
Surgical site infections (SSI) remain a pervasive problem in the United States today
causing significant human and financial cost. SSI is defined as an infection that develops up to 30 days
after a procedure without an implant and up to one year after procedure with an implant (Khairy et al.,
2011, p. 114). More specifically the CDC defines SSI as an infection where depth and tissue spaces are
involved. Superficial infection includes the skin and subcutaneous tissue. A deep incisional SSI includes
the fascia and muscle layers and finally, an organ space SSI involves any part of the body opened or
manipulated during a procedure excluding the other types of SSI previously mentioned. Figure 1 (Ban et
al., 2017, p. 59, Pear, 2007).

Figure 1(Pear, 2007, p. 58-59)
Medical Illustration Copyright © 2006 Nucleus Medical Art, All rights reserved. www.nucleusinc.com
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The CDC indicated there were 16 million procedures performed in hospitals in the United States
in 2017 ("CDC Event," January 2017). They also report a 3% mortality rate (480,000) associated with
SSIs. Of those 75% of total deaths (36,000) were directly associated with SSI. This despite advances in
infection control, better operating room ventilation, antimicrobial prophylaxis, better sterilization
procedures, physical barriers, and surgical technique ("CDC Event," January 2017, Bratzler & Houck,
2004, Wong, Kumar, Bohra, Whetter, & Leaper, 2007). Biddle and Shah performed a study
demonstrating the importance of hand washing by non surgical personnel, specifically the anesthesia
team (Biddle & Shah, 2012).
Tanner et.al. published an article studying the actual human costs of SSIs (Tanner, Padley,
Davey, Murphy, & Brown, 2012). For the patient this is not the mere diagnosis but the physical
manifestations such as smelly discharge, more surgeries, more pain etc. Making the patients voice
heard is invaluable to knowing the overall impact of this problem. These qualitative data on what the
patients perceive are very important for the staff of the operating room, as this is where most
preventative measures take place. The operating room staff often are unaware of what patients with a
SSI endure. In this study a theme emerged where patients described their feelings as utter despair due
to the pain and constant “smelly” leaking from the infection. This made patients and their families
endure severe psychological stress (Tanner et al., 2012, p. 164).
SSI is more than just an increase in length of stay during the initial recovery period. Often
patients develop SSIs after discharge and require readmission. Wong reported in1999 length of stay due
to SSI ranges from 1.3 to 23.8 days. It is estimated to carry a direct financial cost of $3,089 per case
(Wong, 1999, p. 722, Ban et al., 2017, Anderson et al., 2014). A study performed in 2014 at the Veterans
Affairs health system put the cost of SSI in better perspective. They looked at infections for all surgery
types and performed risk adjustments. The authors found risk-adjusted costs for those with an SSI to be
1.25 times higher than those without SSI. The largest cost difference was in patients with a deep SSI.
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The risk-adjusted difference was 1.93 times or a mean difference of $23,755 (Schweizer, Cullen,
Perencevich, & Vaughan Sarrazin, 2014) The cost of SSI in the United States is estimated to be $3.5 - $10
billion annually (Ban et al., 2017). This study in 2016 found SSI increased length of stay (LOS) by 9.7 days
and the cost by more than $20,000 for each admission (Ban et al., 2017). Pellegrini et al. stated SSI was
the most common cause of readmission following hysterectomy accounting for 28.8% of total
readmissions (Pellegrini et al., 2017). It is estimated that among all SSIs, 60% are preventable using
evidenced based best practices. With this knowledge, SSI has become a pay-for-performance metric
and part of quality improvement measures resulting in a financial impact where third party payers will
not pay for readmissions (Ban et al., 2017, p. 59).
The literature is fraught with studies that describe the toll that SSIs take on patient mortality
and morbidity, patient and institutional costs and emotional distress, yet despite this it is difficult to
show an association between coexisting diseases and SSI. The primary reason this is so difficult is that it
is difficult to randomize these type of studies. Multiple publications have attempted to do this through
the promotion of practice guidelines, consensus statements and prospective studies. Despite this, the
SSI rate remains around 3%. (Anderson et al., 2014, Ban et al., 2017, Bratzler &, 2006, Pear, 2007,
Pellegrini et al., 2017, Anjum et al., 2017).
The purpose of this study is to determine the 10-year trajectory of risk of abdominal SSI: by
examining coexisting diseases, hospital issues, patient characteristics and regional variations. Answers
to these questions are expected to lead to a better understanding of the impact of awareness and
programming that have steadily been increasing to address this problem.

Problem Statement: What are the leading risk factors of surgical site infection after abdominal
surgeries over the past 10-years?
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The study population will be those who have undergone abdominal surgeries between 2004
and 2014 (Hubner et al., 2011). Health Care Utilization Project (HCUP) data will be utilized. Specific
ICD-9 codes will be listed later in this paper. Colorectal surgery is associated with the highest SSI rate for
those undergoing elective surgery (Broach, Paulson, Scott, & Mahmoud, 2017). According to
Hubner SSIs account for almost 25% of all nosocomial infections with approximately 5% being due to
SSIs (Hubner et al., 2011). Of the SSIs colorectal surgeries account for about one fifth of all reported
SSIs, the largest number by far (Hubner et al., 2011). Study data will come from the National Inpatient
Sample (NIS) database part of the Hospital Cost and Utilization Project (HCUP) collected by the Agency
for Health Care Research and Quality (AHRQ), part of the Department of Health and Human Services. A
ten percent sample of this database will be taken from the 10-year time span 2004-2014. The study will
attempt to determine if the risk factors for abdominal SSIs have remained the same over a ten-year
period or if changes have occurred.
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CHAPTER 2
Initial studies
The first attempt to understand Surgical Site Infections (SSI) beyond the individual level
and more on a population level was published in the late 1990s. Dr. Cruse in Alberta, Canada received
credit for this study (Assen & Lampard, 2015). These researchers concluded that retrospective studies
using patients’ health records were not good enough because they are often incomplete and inaccurate
(Sullivan, Gupta, & Cook, 2017). From a metanalysis consisting of 26 studies performed between 1998
to 2013, SSI was the third costliest of all hospital acquired infection (HAI) (Sullivan et al., 2017). It is
estimated HAIs cost the health care system 9.8 billion annually (Sullivan et al., 2017). SSI was
responsible for 33.7%, the largest portion of the 5 most common HAIs (Sullivan, Gupta, & Cook, 2017).
In 2008, SSIs were the most common infection in the hospital, accounting for nearly 20% of the two
million infections reported annually (Shepard et al., 2013). SSIs often result in readmissions, additional
surgeries, prolonged courses of antibiotics, and months of physical therapy (Shepard et al., 2013,
(Schweizer et al., 2014). The Centers for Medicare and Medicaid (CMS) has determined SSIs are
preventable and therefore no longer pay for the management of patients that acquire SSIs (Schweizer,
Cullen, Perencevich, & Vaughn Sarrazin, 2014).
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Risk Scores

In 2013, Carl van Walraven et al developed a surgical site infection risk score (SSIRS) (Walraven
& Musselman, 2013). They used data from the 2010 Surgical Quality Improvement Program.
Multivariate logistic regression was used to determine the independent association between patient
characteristics and the risk of all types of SSIs (Walraven & Musselman, 2013). They further stratified
the results by grouping surgeries based on the first three numbers of Current Procedural Terminology
(CPT) codes (Walraven & Musselman, 2013). The authors found risk of SSI increased in certain patients
(Walraven & Musselman, 2013). Patients with comorbidities such as peripheral vascular disease,
metastatic cancer, and steroid use were found to have increased risk of SSIs (Walraven & Musselman,
2013). Patient specific factors found to increase the risk of SSIs included increased body mass index, and
smoking (Walraven & Musselman, 2013). Surgical effects that increase the risk of SSI included operative
time, surgical urgency, higher American Association of Anesthesiologist (ASA) score, infected wounds,
general anesthesia, and more than one procedure or CPT code (Standard codes for all medical
procedures) (Walraven & Musselman, 2013). The authors cite previous studies that provide significant
risk factors for a broad range of surgeries using the National Nosocomial Infections Surveillance (NNIS).
This is a surveillance system sponsored by the Center for Disease Control to track nosocomial infections
nationwide. They state using the NNIS method is limited due to a small number of potential scores.
The previous model had poor validity in weighting of scores. The authors derived a means to overcome
the issues of validity (Walraven & Musselman, 2013). The CDC developed a National Nosocomial
Infection Surveillance (NNIS) risk index as illustrated in Table 1. This table shows, according to the NNIS
cumulative risk summary, that colon surgery has the highest risk of developing a SSI (Pear, 2007).
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Table 1 NNIS Risk Summary
Risk Category
Type of Operation

0

1

2

3

Colon Surgery

3.2

8.5

16.0

22.0

Vascular Surgery

1.6

2.1

6.1

14.8

Cholecystectomy

1.4

2.0

7.1

11.5

Organ Transplant

0.0

4.4

6.7

18.0

(Pear, 2007, p 59)

The risk index by Pear was developed to be able to compare facilities with differing levels of
comorbidities (Pear, 2007). This index is a zero to three scale based on three variables. Each of the
following variables receives one point. The patient has a procedure as classified contaminated or dirty.
American Society of Anesthesiologist (ASA) score of 3,4 or 5 (Table 2) and the duration of surgery
exceeds the 75th percentile of operation time of the NNIS data-base (Table 3) (Pear, 2007).
Table 2

ASA Score of Patient Physical Status
Class I A patient in normal health
Class II A patient with mild systemic disease resulting in no functional limitations
Class III A patient with severe systemic disease that limits activity, but is not incapacitating
Class IV A patient with severe systemic disease that is a constant threat to life
Class V A moribund patient not likely to survive 24 hours

(Pear, 2007, p. 58)
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Table 3
The T Point for Common Surgical Procedures
Operation

T Point (hrs.)

Coronary artery bypass graft

5

Bile duct, liver or pancreatic surgery

4

Craniotomy

4

Head and neck surgery

4

Colonic surgery

3

Joint prosthesis surgery

3

Vascular surgery

3

Abdominal or vaginal hysterectomy

2

Ventricular shunt

2

Hemiorrhaphy

2

Appendectomy

1

Limb amputation

1

Cesarean section

1

(Pear, 2007, p. 58)

There have been several authors that have conducted studies to create a surgical site infection
risk score (Walraven & Musselman, 2013). They concluded a risk score could be calculated using the
patient’s health information and the surgery type to predict SSI risk over a wide variety of surgery types
(Walraven & Musselman, 2013). They created a system calculation that could be completed without a
calculator for ease in determining SSI risk (Walraven & Musselman, 2013). These data points were from
the American College of Surgery National Surgical Quality Improvement Program (ASC-NSQIP). This
organization collects pre-operative and morbidity data on all patients meeting the study criteria over a
thirty-day period. Certified clinical reviewers collected and entered the data (Walraven & Musselman,
2013). Data (cases) collection was in eight-day cycles at participating hospitals. They included either all
specialties or just general and vascular surgery depending on the services offered at the study facilities.
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Excluded were patients aged less than 18, acute trauma, transplant patients, or organ donors. Other
exclusions included inguinal hernia repair, lumpectomy of the breast, laparoscopic cholecystectomy and
transurethral resection. Lastly, patients were also excluded if the procedure was included in the
previous eight-day sample or included within the last thirty days (Walraven & Musselman, 2013). The
primary outcome measure was a SSI within thirty days of the operation. All infections, superficial, deep
and organ space, were collected. All preoperative and intraoperative covariates were collected as long
as the variant had less than 1% missing data (Walraven & Musselman, 2013).
A study conducted in 2016 also created a risk score for SSI in which the researchers looked
specifically at vascular surgeries and they compared eighty-four cases with one hundred sixty controls.
The preoperative independent variables the authors used were critical limb ischemia, a previous SSI,
prior revascularization procedure, and chronic obstructive pulmonary disease (Leekha et al., 2016).
Even though there are many more patient, provider and procedural factors that makes patients
susceptible to SSI the authors concentrated on the above elements to develop the scoring system. They
included cases involving the abdominal aorta and peripheral arteries, as well as endovascular
procedures that required a surgical incision and excluded upper limbs, pulmonary surgery and
percutaneous cases (Leekha et al., 2016). The result of this study is a score that shows a risk of SSI
based on preoperative characteristics (Leekha et al., 2016). Furthermore, the outcome of this study,
according to the authors, provides an “impetus for strict adherence to evidenced based
recommendations for SSI prevention in the preoperative and perioperative period.” (Leekha et al.,
2016). According to Leekha et.al, even though Surgical Care Improvement Project (SCIP) measures are
followed, almost universally, SSI rates remain high (Leekha et al., 2016). This suggests the need to
implement patient centered treatments (Leekha et al., 2016).
Pellegrini et.al. developed a “bundle” consisting of four domains and six areas of focus to
prevent SSI see figure 2 (Pellegrini et al., 2017).
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Figure 2 Domains to Prevent SSI
Readiness (Every Facility)
1. Establish standard preoperative care instructions and education for women undergoing major gynecologic surgery (such as hysterectomy),
including postoperative wound care instructions (written and verbal)
2. Establish a system that delineates responsibility for every member of the surgical team
3. Establish standards for temperature regulation with regard to:
• Ambient operating room temperature
• Patient normothermia
4. Standardize the selection and timing of administration of prophylactic antibiotics, ideally using order sets or checklists
5. Standardize the timing of discontinuation of prophylactic antibiotics, ideally using order sets or checklists
6. Establish standard on appropriate skin preparation, both preoperatively and postoperatively
Recognition and Prevention (Every Patient)
7. Assess patient risk preoperatively for surgical site infection using the following criteria:
• Blood glucose level
• Body mass index
• Immunodciency
• Methicillin-resistant Staphylococcus aureus status
• Nutritional status
• Smoking status
Response (Every Case)
8. Develop intraoperative “Timeouts” to address antibiotic dosage, timing, prophylaxis issues, and patient-speci c issues
9. Reassess patient risk for surgical site infection based on length of surgery, potential bowel incision, vaginal contamination, and amount of
blood loss
10. Provide postoperative care instructions and education to women undergoing major gynecologic surgery (such as hysterectomy) and family
members or other support persons
Reporting and Systems Learning (Every Facility)
11. Establish a culture of huddles for high-risk patients
12. Create system to analyze and report surgical site infection data
13. Monitor outcomes and process metrics
14. Actively collect and share physician-specific surgical site infection data with all surgeons as part of their ongoing professional practice
evaluation
15. Standardize a process to actively monitor and collect surgical site infection data with post discharge follow-up

(Pellegrini et al., 2017)

Surveillance

There have been several studies dealing with guidelines to decrease the incidence and severity
of SSI. The problem with determining the true rate of SSI is the methods of surveillance. Anderson et.al.
and Pear discuss several methods (Anderson et al., 2014, Pear, 2007). Direct surveillance is the gold
standard. With direct surveillance the provider, or their team, directly monitor the patient for SSI. The
high cost and time required for this process makes it rarely utilized. Indirect surveillance may involve all
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or parts of a number of procedures or processes. One is a review of microbiology reports and medical
records. Surgeon and patient surveys are another form of indirect surveillance; these may pick up some
infections that occur after discharge. Additionally, screening of hospital data to determine readmissions
and return to the operating room (OR) may be performed. Lastly is the screening of databases
containing coded diagnosis, coded procedures, operative reports or antimicrobials ordered. The benefit
of indirect surveillance is less cost and time. This method is very reliable and specific (sensitivity 8489%) (specificity 99.8%) (Anderson et al., 2014, Pear, 2007). Review of nursing notes, ICD – 9/10 codes
and antibiotics used shows the highest sensitivity (Anderson et al., 2014, Pear, 2007). The third method
uses automated hospital databases including claims, diagnosis and procedure codes, antibiotic days,
readmissions, returns to the OR, surgical procedure data, and culture data (Anderson et al., 2014, Ban et
al., 2017, Pear, 2007). Automated data increases the sensitivity of the indirect methods (Anderson et
al., 2014, Ban et al., 2017, Pear, 2007, Pellegrini et al., 2017).
Post discharge surveillance is an area requiring improvement. Several studies report this as an
area where SSI data is not routinely collected (Anderson et al., 2014, Ban et al., 2017, (Pear, 2007). The
significance of this omission is that outpatient surgery has increased dramatically in the last 30 years
increasing the risk of missing SSIs related to these surgeries. Additionally, during this same time period,
postoperative lengths of stays have decreased (Ban et al., 2017, Anderson et al., 2014, Pear, 2007).
These issues represent a lost opportunity to improve healthcare, patient safety, and SSI prevention.
Postoperative surveillance can vary by organism, surgical procedure, operative setting, and ultimately
the surveillance technique used (Ban et al., 2017, Anderson et al., 2014, Pear, 2007). Issues related to
postoperative surveillance include first and foremost no standardized postoperative methods for followup. Patients do not return to surgery centers for follow up appointments and superficial infections are
usually treated at home. It is estimated 10.5% of SSIs in colon surgery are detected after the patients
are discharged to home (Ban et al., 2017, Anderson et al., 2014, Pear, 2007).
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Existing Guidelines
The CDC and Health Care Infection Control Practices Advisory Committee (HICPAC) published
their guidelines on SSI in 1999 (Ban et al., 2017, Bratzler & Houck, 2004, Bratzler, 2006). The National
Institute for Health and Clinical Excellence (NICE) from the United Kingdom published their guidelines in
2001 (Ban et al., 2017, Bratzler & Houck, 2004, Bratzler, 2006). The Surgical Infection Prevention (SIP)
was created by CMS in 2002. SIP/SCIP identified three quality improvement (QI) initiatives concerning
antibiotic prophylaxis. The first QI initiative is that antibiotics should be administered one hour before
incision however, some research has shown administration closer to incision is more effective (Ban et
al., 2017, Bratzler & Houck, 2004, Bratzler, 2006, Deierhoj, Dawes, Vick, Itani, & Hawn, 2013). The time
to incision can be up to two hours after antibiotic administration for vancomycin and flouroquinolones.
The second QI initiative indicates that antibiotic medication should be chosen in accordance with
published guidelines and the third QI initiative is that antibiotics should be discontinued twenty-four
hours after surgery (forty-eight hours for cardiovascular surgery) (Ban et al., 2017, Bratzler &, 2006,
Bratzler, 2006, Bratzler & Houck, 2004). SIP focused on seven procedures for which to apply these
initiatives :abdominal hysterectomy, vaginal hysterectomy, hip and knee arthroplasty, cardiac, vascular
and colorectal surgery Ban et al., 2017, (Bratzler, 2006). Many institutions saw a decrease in SSI, after
instituting these guidelines (Ban et al., 2017).
SCIP was created in 2003 and was a continuation of SIP and included three additional evidenced
based measures (Ban et al., 2017). The first measure was for proper hair removal versus no removal.
Removal via clippers or depilatory is acceptable and the use of a razor, except on the scrotum or scalp, is
inappropriate (Ban et al., 2017, Bratzler & Houck, 2004). In 2012, this measure was discontinued
because of near universal compliance. The second measure was monitoring and control of blood
glucose levels during surgery and immediately post op (Ban et al., 2017, Bratzler & Houck, 2004). The
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third measure includes the maintenance of normothermia during the perioperative period for
procedures 60 minutes or greater (Ban et al., 2017, Bratzler &, 2006).
Joint Commission National Patient Safety Goals were established, and used as evidenced based
practices for recommendations (Anderson et al., 2014, "Joint Commission," 2017, "CMS VBP," 2017).
These recommendations led to federal requirements including when CMS enacted the Deficit Reduction
Act of 2005, which required hospitals paid by Medicare to receive payments only after the reporting of
quality measures (Anderson et al., 2014, "Joint Commission," 2017, "CMS VBP," 2017). Reporting on
seven SCIP measures as part of the Hospital Inpatient Quality Reporting (IQR) system was included in
these regulations (Anderson et al., 2014, "Joint Commission," 2017, "CMS VBP," 2017). Three of these
measures focus on SSI reduction. An additional requirement is the report of SSI rates for patients
undergoing abdominal hysterectomies and colorectal surgery via the National Healthcare Safety
Network (NHSN) (Anderson et al., 2014, "Joint Commission," 2017, "CMS VBP," 2017). Performance of
these SCIP measures impact hospital payment under Value Based Purchasing (VBP) (Anderson et al.,
2014, "Joint Commission," 2017, "CMS VBP," 2017).
Current and historical SSI reporting and surveillance has been poor. In order for there to be
accurate reporting the public must understand the definition and types of SSI. Ming et.al. believed
eliminating outpatient superficial SSI would minimize the variability in overall SSI rate (Ming, Chen,
Miller, Sexton, & Anderson, 2012). Most infections in the study were inpatient and those reported by
outpatients were superficial. Physician letters were used to find cases of patients in the outpatient
settings. Of the letter sent to physicians who had performed surgeries in the outpatient setting only 57%
were returned (Ming, Chen, Miller, Sexton, & Anderson, 2012). How different hospitals reported SSI
was associated with the determination of performance scores for the facility (Ming, Chen, Miller,
Sexton, & Anderson, 2012). The best performing facilities in this study only reported complex inpatient
infections, not superficial outpatient infections. Reporting SSI rates to the public remains controversial
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due to the variations and inconsistencies in reporting. At the time of this study, all SSIs were considered
equal and there are consequences to reporting SSI rates without standardization (Ming, Chen, Miller,
Sexton, & Anderson, 2012). The Chalfine et.al. and Miner et.al. studies both used a computer system to
capture SSI. One used laboratory data looking for pathology of wounds. Another approach utilized was
screening across charts for indicators. Scanning billing data was not as accurate as looking at the patient
charts. Surveillance has been associated with decreased rates. However, it remains time consuming
and inaccurate (Chalfine et al., 2006, Miner et al., 2004).

Infrastructure

There are infrastructure related measures used to monitor, and possibly prevent SSI. The
importance of training staff in surveillance cannot be underestimated. Personnel must have the
knowledge and ability to prospectively utilize CDC/NHSN data within the definition of SSI. Computer
and math skills will allow for data acquisition and analysis. Education and feedback has to be given to
providers and families with SSI risk factors (Anderson et al., 2014).
Continuing education is required of the surgeons regarding perioperative risk factors and what
the recommended interventions are for implementation of risk-reduction programs/processes
(Anderson et al., 2014). When teaching interventions, it is often helpful to combine several to make
them easier to remember (Anderson et al., 2014). Further education is required in outcome measures
associated with SSI and the measures needed to prevent such infections. Lastly, infrastructure with
computer assisted decision support and automated reminders aids surveillance (Anderson et al., 2014).
They can tell when to dose and redose. IT infrastructure must be created and used for data transfer,
receipt, and organization for tracking outcomes. The downside of automation is the expense (Anderson
et al., 2014).
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There are basic practices to minimize SSI. Each will be discussed in detail later in this paper.
These measures include antibiotic usage and timing. Not only is timing important but the provider must
consider the pathogen, patients weight and if a combination of agents is appropriate. Hair removal if
necessary and glucose control remains controversial in preventing SSI. Patients’ temperature as related
to surgical time is a major risk factor (Anderson et al., 2014). Tissue oxygenation during and after
surgery, the choice of skin preparation and the use of appropriate wound coverage post operation are
all important factors in preventing SSI. The World Health Organization (WHO) recommends a checklist
(Anderson et al., 2014). The performance of surveillance and a method of disseminating the data to the
providers are important (Anderson et al., 2014). Anderson lists special approaches to prevent SSIs. One
is screen for Staphylococcus aureus and treat prophylactically to decolonize the patient preoperatively
(Anderson et al., 2014). To date there are no standard procedures to complete this task. An important
measure mentioned in this study and others is the potential utilization of a standard SSI risk assessment
tool. A monitoring program for the OR staff and the procedures used should be created. The Post
Anesthesia Care Unit (PACU) staff is important in preventing SSI and should have an education and
monitoring program (Anderson et al., 2014).
Ban et.al. performed a PubMed search on all current topics dealing with SSI. Based on this
information they created the following tables with current guidelines and consensus statements
regarding SSI figures 3,4 and 5 (Ban et al., 2017).
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Figure 3 Pre-hospital interventions
Guideline

Intervention

1.1.
Preoperative
bathing

Routine preoperative bathing with chlorohexidine (when not part of a
decolonization protocol or preoperative bundle) decreases skin surface
pathogen concentrations, but has not been shown to reduce SSI.

1.2. Smoking
cessation

Smoking cessation 4 to 6 weeks before surgery reduces SSI and is
recommended for all current smokers, especially those undergoing procedures
with implanted materials. There is no literature to support cessation of
marijuana and electronic cigarette use to prevent SSI, but cessation is
recommended before surgery based on expert consensus.
American College of Surgeons patient education materials support the use of
nicotine lozenges, nicotine gum, and medication to aid in smoking cessation.

1.3. Glucose
control

Optimal blood glucose control should be encouraged for all diabetic patients;
however, there is no evidence that improved Hgb A1C decreases SSI risk.

1.4. MRSA
screening

Decision about whether or not to implement global Staphylococcus
aureus screening and decolonization protocols should depend on baseline SSI
and MRSA rates.
Clinical practice guidelines from the American Society of Health-System
Pharmacists recommend screening and nasal mupirocin decolonization for S
aureus -colonized patients before total joint replacement and cardiac
procedures.
MRSA bundles (screening, decolonization, contact precautions, hand hygiene)
are highly effective if adhered to, otherwise there is no benefit.
No standard decolonization protocol supported by literature; consider nasal
mupirocin alone vs. nasal mupirocin plus chlorhexidine gluconate bathing.
Decolonization protocols should be completed close to date of surgery to be
effective.
Vancomycin should not be administered as prophylaxis to MRSA-negative
patients.

1.5. Bowel
preparations

Combination mechanical and antibiotic (po) preparation is recommended for all
elective colectomies.

(Ban et al., 2017, p. 61)
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Figure 4 Hospital Interventions
Guideline

Intervention

2.1. Glucose
control

Hyperglycemia in the immediate preoperative period is associated with an
increased risk of SSI.
Target perioperative blood glucose should be between 110 to 150 mg/dL in
all patients, regardless of diabetic status, except in cardiac surgery patients
where the target perioperative blood glucose is <180 mg/dL.
Target blood glucose rates <110 mg/dL have been tied to adverse outcomes
and increased episodes of hypoglycemia and do not decrease SSI risk.

2.2. Hair removal

Hair removal should be avoided unless hair interferes with surgery.
If hair removal is necessary, clippers should be used instead of a razor.

2.3. Skin
preparation

Alcohol-containing preparation should be used unless contraindication
exists (e.g. fire hazard, surfaces involving mucosa, cornea, or ear).
No clear superior agent (chlorhexidine vs. iodine) when combined with
alcohol.
If alcohol cannot be included in the preparation, chlorhexidine should be
used instead of iodine unless contraindications exist.

2.4. Surgical
hand scrub

Use of a waterless chlorhexidine scrub is as effective as traditional water
scrub and requires less time, but there is no superior agent if used
according to manufacturer instructions.

2.5. Surgical
attire

There is limited evidence to support recommendations on surgical attire.
Joint Commission and Association of Perioperative Registered Nurses
policies support facility scrub laundering and the use of disposable bouffant
hats.
American College of Surgeons guidelines support the use of a skull cap if
minimal hair is exposed, removing or covering all jewelry on the head and
neck, and professional attire when outside the operating room (no scrubs or
clean scrubs covered with a white coat).

2.6. Antibiotic
prophylaxis

Administer prophylactic antibiotics only when indicated.
Choice of prophylactic antibiotic should be dictated by the procedure and
pathogens most likely to cause SSI.
Prophylactic antibiotic should be administered within 1 hour before incision
or within 2 hours for vancomycin or fluoroquinolones.
Prophylactic antibiotic dosing should be weight-adjusted.
Re-dose antibiotics to maintain adequate tissue levels based on agent halflife or for every 1,500 mL blood loss
There is no evidence that prophylactic antibiotic administration after incision
closure decreases SSI risk; prophylactic antibiotics should be discontinued
at time of incision closure (exceptions include implant-based breast
reconstruction, joint arthroplasty, and cardiac procedures where optimal
duration of antibiotic therapy remains unknown).

2.7.
Intraoperative
normothermia

Maintain intraoperative normothermia to reduce SSI risk. Preoperative
warming is recommended for all cases, and intraoperative warming methods
should be employed for all but short, clean cases.
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Guideline

Intervention

2.8. Wound
protectors

Use of an impervious plastic wound protector can prevent SSI in open
abdominal surgery. Evidence is strongest for elective colorectal and biliary
tract procedures.

2.9. Antibiotic
sutures

Triclosan antibacterial suture use is recommended for wound closure in
clean and clean-contaminated abdominal cases when available.

2.10. Gloves

The use of double gloves is recommended.
Changing gloves before closure in colorectal cases is recommended,
however, rescrubbing before closure in colorectal cases is not
recommended.

2.11. Instruments

The use of new instruments for closure in colorectal cases is
recommended.

2.12. Wound
closure

No high-quality evidence about delayed primary closure vs. primary closure
and SSI for contaminated and dirty incisions.
Purse-string closure of stoma sites recommended over primary closure.

2.13. Topical
antibiotics

Topical antibiotics can reduce SSI for specific cases, including spine
surgery, total joint arthroplasty, and cataract surgery, but there is insufficient
evidence to recommend routine use at this time.

2.14.
Supplemental
oxygen

The administration of supplemental oxygen (80%) is recommended in the
immediate postoperative period after surgery performed under general
anesthesia.

2.15. Wound
care

There is no evidence in the literature that timing of dressing removal
increases SSI risk.
Early showering (12 hours postoperative) does not increase the risk of SSI.
Use of wound vacuum therapy over stapled skin can reduce SSI in open
colorectal (abdominal incision) and vascular (groin incision) cases.
Mupirocin topic antibiotic application can decrease SSI compared with a
standard dressing.
Daily wound probing can decrease SSI in contaminated wounds.

(Ban et al., 2017, p. 62-63)
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Figure 5 Post Discharge interventions
Guideline Intervention
3.1

Wound care
No formal wound care protocol has been described that decreases the risk of
surgical site infection.

3.2

Surgical site infection surveillance
No reliable post-discharge surgical site infection surveillance method has been
identified.

(Ban et al., 2017, p. 63)
Also published in 2017, was a review of all current literature with recommended changes from
1999 guidelines (Berrios-Torres et al., 2017). The recommendations that came from this study can be
seen in figure 6.
Figure 6

Recommendation Categories
Recommendations were categorized using the following standard system that reflects the level of supporting
evidence or regulations:
Category IA: A strong recommendation supported by high to moderate–quality evidence suggesting net
clinical benefits or harms.
Category IB: A strong recommendation supported by low-quality evidence suggesting net clinical benefits or
harms or an accepted practice (Eg, aseptic technique) supported by low to very low–quality
evidence.
Category IC: A strong recommendation required by state or federal regulation.
Category II: A weak recommendation supported by any quality evidence suggesting a trade-off between
clinical benefits and harms.
No recommendation/unresolved issue: An issue for which there is low to very low–quality evidence with
uncertain trade-offs between the benefits and harms or no published evidence on out- comes deemed
critical to weighing the risks and benefits of a given intervention.

(Berrios-Torres et al., 2017, p 786)

There are numerous risk factors for SSI both intrinsic (patient related some modifiable others
not modifiable) and extrinsic such as the procedure, the facility, preoperative and operative factors.
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Examples of modifiable factors are patient blood glucose and DM status, dyspnea and oxygenation,
alcohol and smoking status, preoperative albumin levels, BMI and immune suppression status (Ban et
al., 2017, Anderson et al., 2014). Non-changeable risk factors are age, sex, procedure type, recent
radiation exposure, and history of skin or soft tissue infection (Ban et al., 2017, Anderson et al., 2014).
Pellegrini et.al. reports the risk of infection goes up when the surgical time increases. The risk was 6.3%
for surgeries one hour or less, this increased to more than 28% for surgeries two hours or longer

(Pellegrini et al., 2017).

Preoperative Bathing

Pre-hospital interventions include bathing, smoking cessation, glucose control, MRSA screening
and decolonization, and bowel preparation before colon surgery (Ban et al., 2017, Anderson et al.,
2014). The intervention of preoperative bathing and showering remains controversial. In an article
published in JAMA, Edmiston made the argument for standardizing the procedure for pre-operative
bathing (Edmiston, Lee, & Krepel, 2015). The authors performed a randomized control trial of two
versus three showers with Chlorohexadine Gluconate 5%. In 1999, the CDC released a patient advisory
committee document, stating an antiseptic bath or shower reduces skin microbe count (Edmiston, Lee,
& Krepel, 2015). A study performed on 700 patients that took two antiseptic showers showed
Chlorohexadine reduced bacterial counts 9 fold while an iodine solution only decreased colony counts
1.3 fold. Showering was “strongly recommended” by the CDC. Although showering has been shown to
decrease bacterial counts, there is no compelling evidence showering has an effect on SSI (Edmiston,
Lee, & Krepel, 2015)
A Cochrane review looked at seven trials regarding pre-hospital antiseptic bathing/showers: six
over a 9-year time span (1983-1992), and one in 2009 (Edmiston et al., 2015, Webster & Osborne, 2015).

LEADING CAUSE OR CAUSES OF SURGICAL SITE INFECTION

25

These reviews suggested the practice of pre operative bathing is not supported (Edmiston et al., 2015,
Webster & Osborne, 2015). Another Cochrane review was a meta analysis published in 2013, looking at
16 trials of 9,980 patients with similar results. In 2015, another Cochrane review was published
comparing any antiseptic used for pre operative bathing or showering or showering with non-antiseptic
solutions (Edmiston et al., 2015, Webster & Osborne, 2015). This update did not reveal any new
findings, and the trials reviewed showed no significance in the reduction of SSI (Edmiston et al., 2015,
Webster & Osborne, 2015).
Edmiston wrote about two important factors of what he called a “low risk, low cost” procedure.
First, the concentration of Chlorohexadine Gluconate on the skin increases with each use. Therefore, a
single shower/application may not provide therapeutic levels. Second, Chlorohexadine binding to
protein on the skin is influenced by the amount applied and the time of exposure. The authors posed
three research questions: 1) Is there a difference in the concentration of Chlorohexadine on the skin of
patients who shower two or three times before surgery?; 2) Would a pause between applications and
rinsing change the concentration.; 3) Is there a volume of Chlorohexadine (118ml) needed for optimal
surface concentration (Edmiston, Lee, & Krepel, 2015). The results of their study showed no significance
between two and three showers, a one to two-minute pause did show higher concentrations of
Chlorohexadine and that there was no difference between 1 or 2 minute soak time. These results show
there is no real evidence regarding the number of showers, soak time or concentrations and the
prevention of SSI (Edmiston et al., 2015).
A study published by Lee looked at nine randomized control trials, which included 3,614 patients
in a meta analysis (Lee, Agarwal, Lee, Fishman, & Umscheid, 2010). The authors concluded bathing with
Chlorohexadine was associated with significantly fewer SSIs when compared with Iodine solutions (Lee,
Agarwal, Lee, Fishman, & Umscheid, 2010). They also found a cost savings of $16-26 per case (Lee,
Agarwal, Lee, Fishman, & Umscheid, 2010). The authors reported the meta analysis showed a moderate
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quality of evidence supporting bathing with Chlorohexadine in decreasing SSI. They also reported a
decrease in positive skin cultures. This meta analysis showed a 36% reduction in SSIs with the use of
Chlorohexadine (Lee, Agarwal, Lee, Fishman, & Umscheid, 2010). The moderate level of evidence was
primarily due to the studies having very few cases of SSI, making the effect seem larger (Lee, Agarwal,
Lee, Fishman, & Umscheid, 2010).

Hair Removal

Preoperative hair removal is another controversial issue. There currently are three methods of
hair removal. They are shaving, clipping, and chemical depilation. Shaving is the most common method
used and the cheapest. The theory is shaving can lead micro nicks in the skin and therefore allow the
entry of microorganisms (Tanner, Norrie, & Melen, 2011). Surgery typically involves preoperative hair
removal from the surgical site. There are studies claiming this may be harmful and cause SSI. Tanner et.
al., published in the Chocrane database a search of studies dealing with preoperative hair removal. The
purpose of these database searches was to determine if shaving does or does not lead to more SSIs
(Tanner, Norrie, & Melen, 2011). The selection criteria were RCTs, comparing no hair removal, different
methods of hair removal and the location of the hair removal at various times in the preoperative
process. Eleven RCTs were reviewed (Tanner, Norrie, & Melen, 2011). Three trials had 625 people and
compared hair removal with either cream or razors with no hair removal. The reviewers found no
significant difference between the groups regarding SSI. There were no trials comparing clipping with no
hair removal (Tanner, Norrie, & Melen, 2011). However, a comparison between shaving and clipping
showed more SSI with the shaving group. The same was true when comparing shaving and cream. The
reviewers concluded the evidence has shown no difference in SSI between those who had hair removed
before surgery and on the day of surgery. They also concluded if hair must be removed then clipping or
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cream should be used as these methods result in less SSI (Tanner, Norrie, & Melen, 2011, Tanner,
Woodings, & Moncaster, 2006, Anderson et al., 2014, (Ban et al., 2017). Torres et al. article published in
JAMA in 2017 the following recommendations concerning bathing and hair removal were made, see
figure 6 (Berrios-Torres et al., 2017).

Figure 6 Bathing and Hair Removal Recommendations
8A.1. Advise patients to shower or bathe (full body) with soap (antimicrobial or non-antimicrobial) or an
antiseptic agent on at least the night before the operative day. (Category IB–strong recommendation; accepted
practice.)
8A.2. Randomized controlled trial evidence suggested uncertain trade-offs between the benefits and harms
regarding the optimal timing of the preoperative shower or bath, the total number of soap or antiseptic agent
applications, or the use of chlorhexidine gluconate washcloths for the prevention of SSI. (No recommendation/
unresolved issue.)
8B. Perform intraoperative skin preparation with an alcohol-based antiseptic agent unless contraindicated.
(Category IA–strong recommendation; high-quality evidence.)
8C. Application of a microbial sealant immediately after intraoperative skin preparation is not necessary for
the prevention of SSI. (Category II–weak recommendation; low-quality evidence suggesting a trade-off
between clinical benefits and harms.)
8D. The use of plastic adhesive drapes with or without antimicrobial properties is not necessary for the
prevention of SSI. (Category II–weak recommendation; high to moderate–quality evidence suggesting a tradeoff between clinical benefits and harms.)
9A. Consider intraoperative irrigation of deep or subcutaneous tissues with aqueous iodophor solution for the
prevention of SSI. Intraperitoneal lavage with aqueous iodophor solution in contaminated or dirty abdominal
procedures is not necessary. (Category II–weak recommendation; moderate-quality evidence suggesting a
trade-off between clinical benefits and harms.)

(Berrios-Torres et al., 2017, p. 787)
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Surgical Preparation

Decontaminating the skin before surgical incision is the standard of care. As newer agents have
been developed so has the interest in topical agents used to prevent SSI. The purpose of a surgical
preparation is to decrease the skin flora. This is important because approximately 2/3 of all SSIs are
superficial. Table 4 shows the most common microorganisms associated with SSI (Sidhwa & Itani, 2015).
Broach et.al. found Escherichia coli was the most common organism isolated in their study (Broach,
Paulson, Scott, & Mahmoud, 2017).

Table 4 Most common isolates from SSI
Pathogen

Proportion of isolates %

Staphylococcus aureus

30.0

Coagulase-negative staphylococci

13.7

Enterococcus spp.

11.2

Escherichia coli

9.6

Pseudomonas aeruginosa

5.6

Enterobacter spp

4.2

Gabsiella pneumonia

3.0

Gabsiella oxytoca

0.7

Acinetobacter baumannil complex

0.6

Other

21.4

(Sidhwa & Itani, 2015, p. 15)
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According to a study by Sidhwa et.al., topical antiseptic skin preparations are more effective at
decreasing SSI than antimicrobial dressings, sutures or topical antibiotics (Sidhwa & Itani, 2015). Much
of today’s research in this area is originally based on early work by Lister conducted in the 1800s
(Sidhwa & Itani, 2015). An ideal agent would kill all bacteria, fungi and spores on the body surface
(Sidhwa & Itani, 2015). The agent should also be non-toxic, hypoallergenic, and non-absorbable. The
effect should last long after application and repeated application should be safe. There are three
common agents used today, although there are others that exist. They are Chlorohexadine gluconate
(CHG), providone-iodine/ iodinepovacrylex (PVI), and isopropyl alcohol (Sidhwa & Itani, 2015). See Table
5.
Table 5. Commercially Available Pre-Operative Skin Preparation Agents
Skin preparation agent
Tincture of iodine
Triclosan
Parachlorometaxylenol
(PCMX)
Sodium hypochlorite
Chlorhexidine gluconate
Povidone-iodine
Iodine povacrylex
Isopropyl alcohol

Comments
Rarely used since introduction of safer and more effective iodophores.
Found in many household items. Effectiveness as a pre-operative antiseptic skin preparation is unproven.
Used as a pre-operative hand/forearm scrub, but inferior to chlorhexidine and povidone-iodine
Excellent chemical disinfectant on non-porous surfaces, but limited effectiveness on skin
Broad-spectrum activity, persistent skin activity, retains effectiveness on contact with organic material, minimal systemic
absorption. Direct instillation may damage inner ear, eyes, and nerve tissue; poorly sporicidal
Broad-spectrum activity including sporicidal activity. Diminished effectiveness on contact with organic material, variable
persistence on the skin, skin irritant, slow-acting
Broad-spectrum activity of povidone-iodine in an acrylate copolymer, believed to resist removal by organic materials and
improve skin persistence
Broad-spectrum, rapid action. Poorly sporicidal, no persistence once evaporated, drying to skin and mucous membranes, highly
flammable

(Sidhwa & Itani, 2015, p. 15)

Randomly controlled trials (RCT) comparing CHG/70% alcohol solution to plain iodine have been
performed resulting in findings that the SSI rate was 9.5% in the iodine group and 7% in the CHG group,
which was not statistically significant (Sidhwa & Itani, 2015). The authors report all the studies they
reviewed show improvement when CHG/alcohol preparations are used (Sidhwa & Itani, 2015). Either
the studies using combination solutions were reported as not significant or this data was omitted from
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the studies. A meta analysis on clean/clean-contaminated cases did show significance with the use of
CHG with and without alcohol over other preparations (Sidhwa & Itani, 2015). Pellegrini et.al. also
wrote there is no consensus on any one preparation that is superior. However, it was found patients
cleaned with a CHG solution in alcohol were 30% less likely to get a SSI (Pellegrini et al., 2017). The
authors concluded it is unlikely a single agent will be found for all cases (Pellegrini et al., 2017).
Furthermore, the agent selected should be based on patient skin type, condition and manufacturers
recommendations (Pellegrini et al., 2017).
The American College of Surgeons defines surgical wounds as follows, (see figure 7).

Figure 7 Surgical Wound Classifications

•

Class I – Clean surgical wounds show no signs of inflammation and do not involve the respiratory,
gastrointestinal or genitourinary tracts. Laparoscopic surgeries, surgeries involving the skin (such as
biopsies), eye or vascular surgeries are good examples.

•

Class II – Clean-contaminated wounds are clean wounds with a higher risk of infection such as those
involving the gastrointestinal, respiratory or genitourinary tracts, as long as the surgery is uncomplicated.
Any wound opened to remove pins or wires, chest procedures, ear surgeries or gynecologic procedures
are considered class II surgical wounds.

•

Class III – Contaminated wounds are created when an outside object comes in contact with the wound.
This could be a bullet, knife blade or other pointy object. Or the contamination could be caused by large
amounts of spillage from the GI tract into the wound. Any highly inflamed or infected tissue around a
surgical wound is considered contaminated.

•

Class IV – Dirty-infected surgical wounds include those with a foreign object lodged in the wound (such as
a bullet or other debris). This class also includes traumatic wounds from a dirty source where the
treatment was delayed, infected surgical wounds or any wound that has been exposed to pus or fecal
matter.

("Wound Care Centers," N.D.)
Overall, the evidence shows a moderate decrease or correlation between skin preparation and SSI.
Studies are often underpowered, have no controls, and no standardization (Sidhwa & Itani, 2015).
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Maiwald et.al. tried to test the efficacy of CHG as a sole agent (Maiwald & Chan, 2012, Sidhwa &
Itani, 2015). The authors found from the meta analysis good evidence of the benefit of CHG/alcohol use
over other agents (Maiwald & Chan, 2012, Sidhwa & Itani, 2015). However, this was not true of other
agents containing alcohol. Among the three most common antiseptic agent’s, alcohol is the most
microbiological, however it has little residual activity (Maiwald & Chan, 2012, Sidhwa & Itani, 2015).
CHG and PVI have less microbiologic effects, however, they both have residual effects CHG > PVI. There
are many products containing alcohol thereby having a high effect on microbes as well as residual
effects (Maiwald & Chan, 2012, Sidhwa & Itani, 2015). Maiwald stated often studies focus on the
primary component and not the alcohol content and hospital policy, at times, is created from these
study results. Maiwald did a systematic review to determine the effect of alcohol in the preparations.
He included 12 studies 2 of which were also meta analysis (Maiwald & Chan, 2012). All studies
evaluated CHG – alcohol preparations, there were no studies with CHG alone. Seven articles included
the alcohol contents in the results, one study had ambiguous statements regarding the alcohol content,
and four included no specific information on alcohol content (Maiwald & Chan, 2012). However, they
did see some benefit from pre-packaged kits and those that contained alcohol (Maiwald & Chan, 2012).
Overall Maiwald found many articles attributed results to the CHG alone and did not attribute any
results to the alcohol content. CHG compounds were better than PVI compounds (Maiwald & Chan,
2012).
Swenson et.al. performed a prospective study on three preoperative surgical site preparations.
3,209 patients were included and they found the PVI scrub paint was the best in preventing SSI common
(Sidhwa & Itani, 2015, Maiwald & Chan, 2012, Swenson et al., 2009). The worst preparation in this
analysis was the CHG/alcohol group. The scrubs studied were the three most common (Sidhwa & Itani,
2015, Maiwald & Chan, 2012, Swenson et al., 2009). As of 2009 the authors state, limited studies have
been performed with SSI as the outcome criteria (Swenson et al., 2009). They used published SCIP
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measures to standardize the procedure (Swenson et al., 2009). Each skin preparation was used for six
months and the patients were followed for 30 days. SSI was diagnosed using the CDC definition
(Swenson et al., 2009). Period one PVI was used, period 2 2% CHG/70% isopropyl alcohol was used, and
period 3 Iodine Povacrylex in isopropyl alcohol was used. The demographics between the groups were
similar. Lowest incidence of SSI was in group 3 (3.9%) compared to period 1 6.4%, and 7.1% in period 2.
These results were found to be significant and most infections that occurred were superficial. There was
no difference found in deep or organ space infections. Other significant findings in this analysis were
female sex relative risk (RR) 1.8, DM 1.67, cancer 1.84, preoperative sepsis 1.73, and preoperative
weight loss 2.17. Operative time was greater in those with SSI by a mean of 80 minutes. The initial
wound class also played a role in the rate of SSI (Swenson et al., 2009).
Broach et.al. performed a study comparing two different alcohol preparations to prevent SSI in
colorectal surgery. They stated the evidence shows alcohol containing preparations were superior for
SSI however, it is unclear if different preparations were equivalent or superior in clean-contaminated
cases (Broach, Paulson, Scott, & Mahmoud, 2017). The authors wrote that IPA (iodine povacrylex and
isopropyl alcohol) and providone iodine with isopropyl alcohol were more effective than CHG in
preventing SSI (Broach et al., 2017). They also wrote a study by Tuuli et.al. showed CHG and alcohol was
more effective after cesarean sections, making choosing the optimal solution difficult (Broach et al.,
2017). Skin preparation remains important in decreasing SSI, the National Quality Forum recommends
the use of alcohol containing scrubs, but do not recommend a specific solution (Broach et al., 2017).
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Hand Washing
Hand washing is perhaps the cornerstone in SSI prevention protocols (Chen, Han, Kan, Chen, &
Hung, 2012, Tanner, Dumville, Norman, & Fortnam, 2016, "AST Standards of Practice for Surgical Attire,
Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17). Traditional protocol is a 3-5minute scrub of hands and nails using 70% isopropyl alcohol and 4% CHG. The use of a waterless alcohol
based scrub has been found to be as effective as traditional scrubs protocols (Chen, Han, Kan, Chen, &
Hung, 2012, Tanner, Dumville, Norman, & Fortnam, 2016, "AST Standards of Practice for Surgical Attire,
Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17). The waterless scrub contains 1%
CHG and 65% alcohol. The protocol used is 5ml placed on the hand and a 3-minute scrub and the
process is repeated in the other hand. At the time of these studies, there were no known studies on
what the optimal hand scrub time should be with waterless scrubs. In 2016, the Cochrane database
published results of 14 studies regarding hand washing. Iodine was found to be inferior. Bacteria
counts were obtained before and after surgery. Given flaws in all the studies, it was unclear if hands
with bacteria caused the SSI. They could not determine how many colony forming units (CFU) were
needed to have an SSI. Another problem was there was no strict adherence to hand washing protocols
(Chen, Han, Kan, Chen, & Hung, 2012, Tanner, Dumville, Norman, & Fortnam, 2016, "AST Standards of
Practice for Surgical Attire, Surgical Scrub, Hand Hygiene (HH) and Hand Washing," Retrieved 8/11/17).
Biddle and Shah performed a study in 2012 observing anesthesia personnel and hand-washing
(Biddle & Shah, 2012). They found a failure rate of anesthesia providers was 64-93%. There were
several areas identified such as moving between patients, keyboard use, during blood draws and IV
placement, during the preparation of medications and equipment, and soiled gloves touching clean
areas after airway manipulation, see table 8 (Biddle & Shah, 2012).

LEADING CAUSE OR CAUSES OF SURGICAL SITE INFECTION

34

Table 8 Anesthesia Providers Contact With Potentially Contaminated Surfaces
Category of Failure
Moving between
patients during the
preoperative
assessment phase
Before, during and
after pain services
Keyboard use with
soiled hands when
using electronic
medical record keeping
Placement of IV lines
and blood draws
Preparing drugs and
equipment
Soiled gloves left on
after airway placed
Soiled gloves left on
after foley catheter or
central/arterial line
manipulation
Other

Example
Contacts patient during examination or IV start and goes on to contact
another patient without appropriate HH
Placing a nerve block using “relaxed” aseptic technique. Failed HH before and
after preoperative nerve block
Keyboard use with soiled gloves on. Failure to perform HH before touching
keyboard and other charting aids

Not wearing gloves during procedure. Failed HH before and after procedures
involving vascular access.
Drawing up drugs, preparing airway devises, IV fluid sets and other equipment
with soiled hands for the next scheduled case while the case is still in
progress.
Intubating or otherwise accessing the airway and failing to remove soiled
gloves or perform HH before touching other items such as keyboards,
flowmeters and others.
Touching the urinary collection bag or a central/arterial line connections or
access site without proper HH

Catch-all category for HH behavior such as picking up something that fell to
the floor and using it (e.g. Suction catheter, roll of tape, and others).
Touching another room provider with soiled hands. Opening sterile packages
or opening anesthesia cart drawers with soiled hands.

(Biddle & Shah, 2012)
They also found that stop cock contamination was very common and provided a direct route of
pathogens to the patients’ blood stream (Biddle & Shah, 2012). They also said that this study holds
anesthesia providers to an impossibly high standard given that at times the care is of critical nature.
However, policies to reduce the rate of poor HH should be pursued (Biddle & Shah, 2012).
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Surgical Attire and Items Taken into the Operating Theater

The American College of Surgeons published the following recommendations for operating
room (OR) surgical attire (See figure 6).

Figure 6. The ACS guidelines for appropriate attire are based on professionalism, common sense,
decorum, and the available evidence. They are as follows:
•
•
•
•
•
•
•

•
•

Soiled scrubs and/or hats should be changed as soon as feasible and certainly prior to speaking with
family members after a surgical procedure.
Scrubs and hats worn during dirty or contaminated cases should be changed prior to subsequent
cases even if not visibly soiled.
Masks should not be worn dangling at any time.
Operating room (OR) scrubs should not be worn in the hospital facility outside of the OR area
without a clean lab coat or appropriate cover up over them.
OR scrubs should not be worn at any time outside of the hospital perimeter.
OR scrubs should be changed at least daily.
During invasive procedures, the mouth, nose, and hair (skull and face) should be covered to avoid
potential wound contamination. Large sideburns and ponytails should be covered or contained.
There is no evidence that leaving ears, a limited amount of hair on the nape of the neck or a modest
sideburn uncovered contributes to wound infections.
Earrings and jewelry worn on the head or neck where they might fall into or contaminate the sterile
field should all be removed or appropriately covered during procedures
The ACS encourages clean appropriate professional attire (not scrubs) to be worn during all patient
encounters outside of the OR.

("American College of Surgeons," 2016)
The AORN has also provided guidance on surgical OR attire. One recommendation in
particular deals with home laundering. They state, “Surgical attire should be laundered by a health care
approved and accredited facility.” This is ideal because there are industry standards regarding
laundering. Home equipment may not be able to remove the bio burden ("AORN," May 30, 2017).
All personnel in the operating theater including anesthesia, circulators, and vendors have a
significant role in minimizing/preventing SSI via laundering of operating room apparel (Vera, Umadhay,
& Fisher, 2016). Despite the guidelines on laundering scrubs, the issue remains controversial. Due to
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the multiple risk factors and possible vectors for SSI it is difficult to ascertain if improper laundering or
wearing dirty scrubs is the cause of such infections (Vera, Umadhay, & Fisher, 2016). Common causes of
fomites in the OR include clothing, personal bags, hospital badges, and pens. Limiting these items limits
the bacterial load that can be transferred to the surgical field, however, again there is no evidence or
indication these actions actually lower the rate of SSI (Vera, Umadhay, & Fisher, 2016). It has been
found that up to 60% of healthcare worker’s uniforms are infected and the concentrations of fomites
tend to be higher at the end of the day and on the scrub bottoms (Vera, Umadhay, & Fisher, 2016). Vera
et.al. stated this is a concern for anesthesia providers as many patients are supine and thus they are
exposed to the area of scrubs with the maximum concentration of bacteria. Again, there are no studies
on what bacterial load leads to infection (Vera, Umadhay, & Fisher, 2016). Even if studies did exist, the
results most likely would vary from patient to patient based on organism, length of procedure, age and
immune status (Vera, Umadhay, & Fisher, 2016).
There has been some evidence of a contaminated laundry facility being associated with SSI
(Vera, Umadhay, & Fisher, 2016). There also is evidence of home laundering causing SSI. One such case
was caused by a nurse anesthetist with a cluster of SSI linked to him/her. The causative bacteria were
found on their clothing and in their home washing machine. This was reported as a rare occurrence and
there are still few correlations between home laundering and SSI (Vera et al., 2016).
How is facility laundering different from home laundering? OSHA describes decontamination as
“the physical means to remove, inactivate or destroy blood borne pathogens from an item to the point
at which it is no longer capable of transmitting infectious particles.” (Vera et al., 2016, p. 248)
“Decontamination is an act that consists of elements such as water temperature, detergents, and
chemicals added for cleaning, dilution, and time of the wash cycle.” (Vera et al., 2016, p. 249) A facility
or facility hired laundering facility will abide by OSHA and CDC laundering guidelines (Vera, Umadhay, &
Fisher, 2016). The newer energy star home machines operate at lower temperatures and water levels
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and therefore these machines may not be able to reach the CDC guideline of 71 degrees centigrade
water temperature (Vera, Umadhay, & Fisher, 2016). Even with the recommendations of the American
College of Surgeons, AORN, CDC and OSHA, some facilities have implemented home laundering policies
(Vera, Umadhay, & Fisher, 2016). The theory is that the dryer heat will be sufficient to eliminate
bacteria. The facilities instituting this policy have seen a large cost savings without an increase in SSI
(Vera, Umadhay, & Fisher, 2016). Even though there are CDC and OSHA guidelines for laundering
currently, there is not a microbial testing requirement of commercial facilities (Vera et al., 2016). The
current OSHA requirement of facilities is the facility must launder employee owned garments if
physically soiled, otherwise they may be laundered at home. If scrubs are home laundered, it is
recommended that the CDC guideline of 40-60 degrees C be followed (Vera et al., 2016).
There are other sources of bacterial shedding in the OR other than the scrubs that are worn
(Owers, James, & Bannister, 2004). Recommendations and guidelines exist for these personal protective
devices and personal effects as well (Owers, James, & Bannister, 2004). It has long been common
practice for the surgical team to wear occlusive gowns, hats and masks to prevent contamination from
the skin. Even so, some facial areas remain exposed such as the forehead, eyebrows and ears. Owers
et.al. found there were more bacteria present from the ears versus the forehead and eyebrows, and as a
result to reduce bacterial load it is recommended to cover the ears with the hat or a hood (Owers,
James, & Bannister, 2004). In May 2017 AORN published the following recommendation “A clean
surgical head cover or hood that confines all hair and completely covers the ears, scalp skin, sideburns,
and nape of the neck should be worn.” ("AORN," May 30, 2017) This statement according to the AORN
has been supported by numerous articles on bacteria sources and SSI ("AORN," May 30, 2017).
The Association of Surgical Technologists has published a comprehensive list of
recommendations to help minimize SSI ("AST Standards of Practice for Surgical Attire, Surgical Scrub,
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Hand Hygiene and Hand Washing," Retrieved 8/11/17). Some additional recommendations are as
follows:
Ø Proper attire must be worn in all restricted/semi-restricted areas ("AST Standards of
Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved
8/11/17).
Ø Surgical head covers should be bouffant style ("AST Standards of Practice for Surgical
Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17).
Ø Skull caps and personal head covers allow too much hair/skin to remain exposed ("AST
Standards of Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and Hand
Washing," Retrieved 8/11/17).
Ø Facial hair should be completely covered ("AST Standards of Practice for Surgical Attire,
Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17).
Ø Disposable head covers should be discarded daily ("AST Standards of Practice for
Surgical Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17).
Ø Masks should be worn in all sterile and sub sterile areas and the mask should be on or
off, never dangling ("AST Standards of Practice for Surgical Attire, Surgical Scrub, Hand
Hygiene and Hand Washing," Retrieved 8/11/17).
Ø The mask should fit tightly with no gaps ("AST Standards of Practice for Surgical Attire,
Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17).
Ø Masks should be changed between cases and if they become saturated("AST Standards
of Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and Hand Washing,"
Retrieved 8/11/17).
Ø Masks should be handled by the strings only ("AST Standards of Practice for Surgical
Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17).
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Ø Scrubs should be facility laundered, never worn outside the facility, and always covered
if outside the operating restricted/semi restricted areas ("AST Standards of Practice for
Surgical Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17).
Ø Scrubs should also be changed after dirty cases, if they become soiled, and at least daily
("AST Standards of Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and Hand
Washing," Retrieved 8/11/17).
Ø Scrubs should never be left in a locker overnight or a span of days as microbes may
continue to grow ("AST Standards of Practice for Surgical Attire, Surgical Scrub, Hand
Hygiene and Hand Washing," Retrieved 8/11/17).
Ø Non-sterile surgical team members should wear facility provided jackets that cover the
arms ("AST Standards of Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and
Hand Washing," Retrieved 8/11/17).
Ø Jackets should remain zipped or snapped to minimize billowing and touching the patient
("AST Standards of Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and Hand
Washing," Retrieved 8/11/17).
Ø Shoe covers should be worn in all restricted or semi restricted areas and should be
discarded daily or when leaving the restricted/ semi restricted areas ("AST Standards of
Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved
8/11/17).
Ø Hand scrubbing should be accomplished with antimicrobial soap or an alcohol based
waterless hand scrub ("AST Standards of Practice for Surgical Attire, Surgical Scrub,
Hand Hygiene and Hand Washing," Retrieved 8/11/17).
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Ø Fingernails should not go beyond the tip of the finger for all people in the operating
room ("AST Standards of Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and
Hand Washing," Retrieved 8/11/17).
Ø For the sterile team nails should be scrubbed under water per earlier guidelines and nail
polish if worn should be fresh and not chipped ("AST Standards of Practice for Surgical
Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17).
Ø Polish that is chipped or more than four days’ old has bacterial counts that increase
exponentially ("AST Standards of Practice for Surgical Attire, Surgical Scrub, Hand
Hygiene and Hand Washing," Retrieved 8/11/17).
Ø No member of the surgical team should have artificial nails ("AST Standards of Practice
for Surgical Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved
8/11/17).
Ø The skin should be free of cuts, rubs and abrasions ("AST Standards of Practice for
Surgical Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved 8/11/17).
Ø All jewelry should be removed before scrubbing. Multiple rings exponentially increase
the bacterial load, and must be removed for proper scrubbing ("AST Standards of
Practice for Surgical Attire, Surgical Scrub, Hand Hygiene and Hand Washing," Retrieved
8/11/17).
Traffic flow in and out of the operating room increases the risk of bacteria in the OR. With more
traffic flow and increases in operating time, the number of CFU/m2 increases as well. Both of these
factors have a negative effect in the OR and increase the risk of SSI (Andersson, Bergh, Karlsson,
Eriksson, & Nilsson, 2012).
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Treatment of Pre-existing Infections

Should we prescreen and treat for Methicillin-resistant Staphylococcus aureus (MRSA)? Patients
colonized with MRSA have a greater risk of SSI (Kalra et al., 2013). MRSA patients have 1.19 times
higher hospital charges than those without MRSA. Median charge per non-MRSA patient was $29,455
versus $92,363 in those with MRSA (Engemann et al., 2003). Older patients with MRSA also had renal
disease. MRSA patients also had longer surgical times and median LOS was 14 days versus 5 for those
without MRSA (Engemann et al., 2003). Allareddy et.al. stated estimates of MRSA rates in hospitalized
patients and their outcomes are not well documented in the United States. Surgical volume, in the
United States, has increased over the last several years and therefore so has the number of MRSA cases
(Allareddy et al., 2015). MRSA is very prevalent in some areas and is a major concern/cause of SSI. The
authors performed a retrospective study of NIS data for 2009 and 2010. All hospitalizations that involved
major surgical procedures as determined by ICD-9 code were selected (Allareddy et al., 2015). They
found a rate of MRSA of 1.03%. Of these 1.7% were already infected with MRSA at the time of
admission (Allareddy et al., 2015). Hospitals in the Northeast and Mid West had lower odds of MRSA as
compared to the West and South (Allareddy et al., 2015). Teaching hospitals had less MRSA when
compared to non teaching hospitals; in addition, hospitals with large numbers of beds had less MRSA
than small and medium hospitals (Allareddy et al., 2015). Punke published in Infection Control & Clinical
Quality that a program testing the nares of patients was very costly for the results provided (Punke,
2014). She found a cost of $103,000 per 10,000 admissions (Punke, 2014). Of these admissions, only
three cases of MRSA were prevented (Punke, 2014). A program targeted to high-risk patients only
resulted in one infection being prevented out of 1,000 admissions, resulting in a $36,899 loss (Punke,
2014). Kalra et.al. concluded in their study, patients with positive MRSA screen had a 9-fold increase in
SSI. The rate of SSI in positive patients was 1.86%. They further suggest if that subset could be
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identified for the greatest risk of SSI, screening may help target them and they may benefit from
decolonization or other interventions (Kalra et al., 2013, Pellegrini et al., 2017).
Bode writes nasal carriers of Staphylococcus aureus are three to six times more likely than low
level and non-carriers to develop a surgical infection (Bode et al., 2010). Some research supports the
use of intranasal mupirocin to help prevent SSI in surgical patients. The study supporting the
effectiveness of mupirocin was a historical data study (Bode et al., 2010). Two other studies showed
mupirocin was not effective in preventing SSI in colonized patients (Bode et al., 2010). Some possible
causes of the failure may have been infected wounds at the time of the positive swab or other extra
nasal areas positive for MRSA (Bode et al., 2010).
Bode et.al. conducted a RCT to test the effect of mupirocin in relation to SSI (Bode et al., 2010).
The results of this RCT were the mupirocin group had fewer S. aureus infections than the placebo group.
The conclusion of this study was rapid detection and treatment of S. aureus decreased HAI and
decreased LOS (Bode et al., 2010). They also recognized these patients had positive extra nasal sites and
a CHG bath was effective in cleaning of those areas (Bode et al., 2010).
There have been many studies performed to determine if sticky drapes or those impregnated
with antimicrobial chemicals can reduce SSI (Swenson, Camp, Mulloy, & Sawyer, 2008, Alghamdi, 2015).
A Cochrane database analysis showed no evidence adhesive drapes decreased SSI. Seven studies with
4000 patients were analyzed to determine the effectiveness of impregnated drapes. Swenson et.al.
studied antimicrobial impregnated drapes. Once again, no difference in SSI was found (Swenson, Camp,
Mulloy, & Sawyer, 2008, Alghamdi, 2015).

LEADING CAUSE OR CAUSES OF SURGICAL SITE INFECTION

43

Age
Age remains a controversial factor in relation to SSI. Kaye et.al. cite an article by McGarry et.al.
stating older patients with S. aeureus SSIs have three times higher mortality, longer LOS, and hospital
charges than younger infected patients (Kaye et al., 2005, Raymond et al., 2001). Some investigators
state older patients have more co-existing disease which may be the factor causing SSI not age. Some
studies have found a decrease in SSI compared to age, especially after discharge to home (Kaye et al.,
2005, Raymond et al., 2001). Kaye et.al. believed a larger cohort study was needed to truly test the age
hypothesis (Kaye et al., 2005, Raymond et al., 2001). Their findings showed some predictable results
such as longer surgical times, ASA > 3 and a wound class >2 were associated with increased SSI. In
regards to age, they found as the mean age up to 65 increased so did SSI. The rate of increase was
1.1%/yr. This was a significant finding. They found age >65 SSI decreased by 1.2%/yr. Raymond found
all infections were higher in the elderly which may be attributed to more coexisting disease (Kaye et al.,
2005, Raymond et al., 2001).
As of 2005, there had not been a established link between age and SSI (Khan, Muqim, Zarin,
Khalil, & Salman, 2010, p. 507). Older patients that had SSI have longer length of surgery, longer length
of stay, mortality and higher cost than younger patients do. Many older patients have more coexisting
disease making them more susceptible to infection. Kaye et.al. did find those with SSI had surgery >75th
percentile NNIS, ASA >3, and wound class >2 (Kaye et al., 2005). The authors concluded age >65 was a
significant predictor of SSI. This effect peaked at 74, and then decreased (Kaye et al., 2005). Khan et.al
defined comorbidity as “any distinct clinical entity that has existed or may occur during the clinical
course of a patient who has a condition under study” (Khan, Muqim, Zarin, Khalil, & Salman, 2010, p.
507).
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Glucose Control

Poor glucose control has been associated with poor outcomes in those with or without diabetes
(Dronge, Perkal, & Kancir, 2006). A study conducted at the VA using NSQI data determined at what
percent hemoglobin A1C was ideal for better outcomes (Dronge, Perkal, & Kancir, 2006). The authors
found age, ASA, length of surgery; wound class and hemoglobin A1C levels were all significantly
associated with postoperative infections. Hemoglobin A1C level less than 7% was significantly
associated with a decrease in infection. This study looked at many infections such as pneumonia, sepsis,
urinary tract infections, and wound infections (Dronge, Perkal, & Kancir, 2006). A study in 2013 stated
there is limited evidence of perioperative hyperglycemia and insulin on poor outcomes in diabetic and
non-diabetic patients (Kwon et al., 2013). The authors found both diabetic and non diabetics had an
increase risk of poor outcomes and those patients that did have high glucose levels on the day of
surgery and received insulin did not have any increase risk of infection, reoperation, or death (Kwon et
al., 2013). They did find a dose effect between glucose control and adverse outcomes, including
infections (worst 180-250 mg/dL and best <130 mg/dL). This is significant as the number of cases of
undiagnosed diabetes on the day of surgery is becoming more prevalent (Kwon et al., 2013 Pellegrini et
al., 2017). These findings make a case for routine glucose testing pre and post operatively (Pellegrini et
al., 2017). The recommendations listed in JAMA in 2017 can be found in figure 8 (Berrios-Torres et al.,
2017).
Figure 8 Glucose Control Recommendations
3A.1. Implement perioperative glycemic control and use blood glucose target levels less than 200 mg/dL in
patients with and with- out diabetes. (Category IA–strong recommendation; high to moderate quality
evidence.)
3A.2. The search did not identify randomized controlled trials that evaluated lower (<200 mg/dL) or narrower
blood glucose target levels than recommended in this guideline nor the optimal timing, du- ration, or delivery
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method of perioperative glycemic control for the prevention of SSI. Other organizations have made
recommendations based on observational evidence, and a summary of these recommendations can be found in
the Other Guidelines section of the narrative summary for this question (appendix 1 of the Supplement). (No
recommendation/unresolved issue.)
3B. The search did not identify randomized controlled trials that evaluated the optimal hemoglobin A1C target
levels for the prevention of SSI in patients with and without diabetes. (No recommendation/unresolved issue.)

(Berrios-Torres et al., 2017, p. 787)

Smoking

Smoking has an effect on surgical outcomes, wound healing, LOS and costs (Hawn et al., 2011,
Sharma et al., 2013). Those patients that currently smoke have significantly higher odds of respiratory
and wound complications up to one year following surgery (Hawn et al., 2011, Sharma et al., 2013,
Pellegrini et al., 2017). Approximately 20% of adults’ smoke, and of those millions have surgery annually
(Hawn et al., 2011, Sharma et al., 2013). The effect smoking has on colorectal surgery is unclear (Hawn
et al., 2011, Sharma et al., 2013). Most studies dealing with smoking are small, underpowered, single
facility and have many confounding factors (Hawn et al., 2011, Sharma et al., 2013). Sharma et.al.
performed a study and found current smokers tended to be younger and drank more alcohol than nonsmokers and ex-smokers. Ex-smokers tended to have higher BMIs, more diabetes, cardiac, pulmonary
and neurologic complications, and ASA status than current and patients who never smoked. They found
current smokers had the highest rates of incisional infections. The number of pack years (number of
cigarettes smoked per year times the years smoked) smoked did not affect the rate of infection (Hawn
et al., 2011, Sharma et al., 2013).
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Temperature Regulation

Hypothermia causes thermoregulatory vasoconstriction, which decreases tissue oxygenation.
This decrease in oxygen tension decreases the oxidative killing of neutrophils and therefore wound
healing is adversely effected (Kurz, Sessier, Lenhardt, &, 1996, Wong et al., 2007). In addition to tissue
oxygenation the immune response is affected (Kurz et al., 1996). Specifically, chemotaxis and
phagocytosis of granulocytes, motility of macrophages and production of antibodies (Kurz et al., 1996).
Wound healing is also related to anesthesia and hypothermia, specifically anesthesia related
hypothermia lowers resistance to E. coli and S. aureus in lab animals (Kurz et al., 1996). Mild
perioperative hypothermia is common in colon surgery, where temperature may be lowered
approximately 2 degrees centigrade (Kurz et al., 1996).
Several studies have considered preoperative warming of patients. Melling et.al. wrote the use
of antibiotics in decreasing SSI is well known especially in clean contaminates and contaminated
surgeries. The goal of their study was to see if preoperative warming was effective in clean, short, same
day surgeries as antibiotics are in the prevention of SSI. They found a lower rate of infection in the
group with combined warming (traditional blanket and forced air) over no warming (Melling, Ali, Scott,
& Leaper, 2001).
General anesthesia can cause a decrease in temperature by as much as 1.6 degrees centigrade.
Hypothermia can lead to significant vasoconstriction and decreased oxygen to the tissues, which has
been shown to increase the risk for SSI (Pellegrini et al., 2017). One standard routinely ignored is the
recommendation by the Association of Perioperative Registered Nurses that the operating suite
temperature be maintained between 68-72 degrees centigrade. Often the reason given is comfort of
the surgical team (Pellegrini et al., 2017).
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The bacterial killing abilities of neutrophils is reliant on oxidative killing. This is a critical process
against surgical pathogens. This process is dependent of tissue oxygen tension (0 – 300 mm hg).
Surgical incision disrupts the vascular supply causing wounds to be hypoxic as compared to surrounding
normal tissue. Wound oxygen tension is often less than 30 mm Hg (Greif, Akca, Horn, Kurz, & Sessler,
2000, Wong et al., 2007).
According to Meyhoff et.al. the use of 80% oxygen intraoperatively has been shown to reduce
SSI, however the pulmonary effects of this concentration have not been well studied (Meyhoff,
Wetterslev, & Jorgensen, 2017). They performed a study using FIO2 of 30 and 80% during and two
hours following surgery. They found an SSI rate of 19.1% in the 80% group and 20.1% in the 30% group.
Atelectasis was 7.9% versus 7.1% in the 80 versus 30% groups. Pneumonia was 6 versus 6.3%;
respiratory failure was 5.5 versus 4.4% between the 80 and 30% groups. The results are the higher O2
concentrations did not affect SSI or pulmonary complications (Meyhoff, Wetterslev, & Jorgensen, 2017).

Bowel Preparation

The use of mechanical bowel preparations (MBP) and oral antibiotic preparations (OAP) before
colorectal surgery is another controversial treatment (Garfinkle et al., 2017, Fry &, 2016). There are
studies, dating back to the 1930s and 1940s showing the use of these preparations are beneficial and
yet others have disputed these findings (Garfinkle et al., 2017, Fry &, 2016). The colon has the highest
concentration of bacteria in the human body, 10 to the 6th to 10 to 7th bacteria/ gram stool in the right
colon and 10 to the 11th power to 10 to the 12th power bacteria/gram stool in the retro sigmoid colon
(Fry &, 2016, (Deierhoj et al., 2013). This may account for the high SSI rate in colorectal surgery (Fry &,
2016, (Deierhoj et al., 2013). RCTs have not been able to show independent protective effects on
infective conditions and this has led to a decline in use (Garfinkle et al., 2017). There must be a
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difference made between the two modalities, MBP and OAP. Recent studies have looked at these
treatments alone and together. They showed combined use was better than MBP alone, however these
studies had small numbers using OAP alone and therefore were underpowered and unable to show an
independent effect (Garfinkle et al., 2017).
Anjum et.al. reports anaerobic colonic bacteria are the major organism responsible for SSI in
colorectal procedures (Anjum et al., 2017). Reducing the count of these bacteria has been reported by
researchers to have a significant effect on SSI. However, the use of oral antibiotics with a mechanical
bowel preparation remains controversial. A survey of colorectal surgeons performed by The American
Society of Colon and Rectal Surgeons showed 10% of those surveyed believed preoperative oral
antibiotics were unnecessary, 40% were doubtful and 50% thought the practice was necessary (Anjum
et al., 2017). Anjum et.al. found the practice did significantly decrease SSI in clean and clean
contaminate surgeries (Anjum et al., 2017).
The Boutros et.al. study assessed the independent and combined effect of MBP and OAP on SSI,
leak at the anastomosis site, major morbidity, and 30-day mortality in a larger cohort (Garfinkle et al.,
2017). They found significant differences among the groups regarding preoperative and demographic
variables. Those who did not receive any bowel preparation compared to MBP, OAP or combined
MBP/OAP were least likely to be white, most likely to be functionally independent, and had the highest
rate of COPD, CHF, ASA >3, least likely to have had a laparoscopic procedure and shorter LOS than no
preparation (Garfinkle et al., 2017). Combined MBP and OAP were protective of all five study variables
(Garfinkle et al., 2017). The variables outside of the type of bowel preparation consistently associated
with SSI included DM, smoking, preoperative steroid use and preoperative hypoalbuninemia. The
authors concluded the recommendations on the use of bowel preparations has come full circle. They
stated there are times when MBP may not be feasible and helpful. A meta analysis of eight RCT for
those undergoing GI surgery was performed. They demonstrated “selective decontamination of the
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digestive tract” significantly decreased postoperative infection (Garfinkle et al., 2017). Berrios-Torres
et.al. list the following recommendations from non-parenteral antibiotics in Figure 9 (Berrios-Torres et
al., 2017).
Figure 9 Nonparenteral Antimicrobial Prophylaxis
2A.1. Randomized controlled trial evidence suggested uncertain trade-offs between the benefits and harms
regarding intraoperative antimicrobial irrigation (e.g., intra-abdominal, deep, or subcutaneous tissues) for the
prevention of SSI. Other organizations have made recommendations based on the existing evidence, and a
summary of these recommendations can be found in the Other Guide- lines section of the narrative summary
for this question (appendix 1 of the Supplement). (No recommendation/unresolved issue.)
2A.2. The search did not identify randomized controlled trials that evaluated soaking prosthetic devices in
antimicrobial solutions be- fore implantation for the prevention of SSI. (No recommendation/ unresolved
issue.)
2B.1. Do not apply antimicrobial agents (i.e., ointments, solutions, or powders) to the surgical incision for the
prevention of SSI. (Category IB–strong recommendation; low-quality evidence.)
2B.2. Application of autologous platelet-rich plasma is not necessary for the prevention of SSI. (Category II–
weak recommendation; moderate-quality evidence suggesting a trade-off between clinical benefits and harms.)
2C. Consider the use of triclosan coated sutures for the prevention of SSI. (Category II–weak recommendation;
moderate-quality evidence suggesting a trade-off between clinical benefits and harms.)
2D. Randomized controlled trial evidence suggested uncertain trade- offs between the benefits and harms
regarding antimicrobial dressings applied to surgical incisions after primary closure in the operating room for
the prevention of SSI. (No recommendation/ unresolved issue.)

(Berrios-Torres et al., 2017)

Preoperative Antibiotics

Fry et.al. states the use of preventative antibiotics is a standard practice to prevent SSI in colon
surgery patients (Fry &, 2016). The aim of the study he published was to show the merit of continuing
the use of MBP. They cited studies from the 1930’s and 1940’s and recent articles showing oral and not
systemic antibiotics reduced SSI and anastomotic leak. In the 1970s, MBP caused discomfort, had large
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volumes to ingest and therefore had poor compliance. Other studies cited by Fry showed oral and
systemic antibiotics did lower SSI. They also stated the use of oral antibiotics must be accompanied with
a MBP to ensure the antibiotic reaches the entire length of the colon. It was noted retained hard stool
increases the bacterial load at the spot of stool (Fry &, 2016).
A Cochrane database published in 2014, shows prophylactic antibiotics prior to colorectal
surgery prevents infection (Hawn et al., 2011, Nelson, Gladman, & Barbateskovic, 2014). The drug
choice, time of administration in relation to surgery and the route are still undetermined. The meta
analysis included 260 studies utilizing 68 different antibiotics. The results show preoperative antibiotics
are successful in decreasing SSI when compared to placebo (Hawn et al., 2011, Nelson, Gladman, &
Barbateskovic, 2014). Results were better with multiple doses (Nelson et al., 2014). Using drugs that
were effective on both aerobic and anaerobic decreased SSI the best (Nelson et al., 2014). A study by
Koch et.al. published in 2013 looked at the optimal timing of the initial dose of antibiotic to reduce SSI
(Koch et al., 2013). The study found the best time is 4 minutes before incision. This resulted in a 11.3%
reduction in the primary endpoint of infection. The authors also found the risk of infection increased as
the time from incision increased. Pellegrini et.al. reported other studies refuted these findings and SSI
actually increased when time to incision was less than 30 min (Koch et al., 2013). The authors wrote that
the 60 minute time frame is questioned in many studies. However, they did report the largest reduction
in infection when cephalosporins were given at the 30 minute mark (Pellegrini et al., 2017). A meta
analysis was performed in 2017 comparing dosage within 120 minutes and greater than 120 minutes
(deJonge et al., 2017). They showed an increase in SSI when the timing was greater than 120 minutes
(deJonge et al., 2017). Yet, another analysis showed lowest SSI rates when cefuroxime was given 15
minutes before incision and vancomycin was given within 30 minutes. Administration 30-60 minutes vs.
0-30 minutes resulted in a 30% higher risk of SSI (deJonge et al., 2017). The timing of antibiotics is a SCIP
measure. Many studies fail to show a relationship between adherence to this SCIP measure and
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decreased SSI. Hawn states the type of antibiotic for the surgical area was associated with decreased
SSI, not timing. However, vancomycin was associated with higher rates of SSI in orthopedic procedures,
cefazolin and quinolone in combination with an anaerobic agent was associated with a decrease in SSI in
colorectal surgeries. The also found and sated SSI risk varies by patient type, procedure, and the
property of the antibiotic (Hawn, Richman, & Vick, 2013, Deierhoj et al., 2013). However, SSI was not
associated with the timing of the antibiotic. Lastly, they said timing is not bad care but may not be
better care (Hawn, Richman, & Vick, 2013, Deierhoj et al., 2013).
Another study by Deierhoi et.al. wrote previous studies linked antibiotic compliance to SCIP not
patients and SSI (Deierhoj et al., 2013). Three large cohort studies neared significance for the antibiotic
selected which suggested the agent chosen may be more important than the timing (Deierhoj et al.,
2013). The authors report two recent cohorts report a significant reduction in colorectal SSI with oral
antibiotics as a part of bowel preparation. SCIP guidelines list several IV antibiotics with oral
preparations being discretionary (Deierhoj et al., 2013). The authors found significant variation in the
different antibiotics used for colorectal surgery specifically second generation cephalosporins were most
commonly used. They were also the least effective among the approved antibiotics (Deierhoj et al.,
2013). Deierhoi et.al. also found oral antibiotics were associated with decreased SSI (Deierhoj et al.,
2013). They wrote there are a number of factors that affect the efficacy of intravenous antibiotics
including surgical technique, patient factors, and the disease process (Deierhoj et al., 2013). They found
within the acceptable antibiotics, the choice for compliance with SCIP measures had large ranges in
adjusted odds for SSI and therefore may be why SCIP adherence may not reduce SSI (Deierhoj et al.,
2013). Further there is a lack of culture data showing resistance to medications and therefore, it is
difficult to know what agent would be the most appropriate (Deierhoj et al., 2013). There has been an
increase in anaerobic infections, the most common being Bacteroides fragilis, with an accompanying
increase in resistance to this family of bacteria (Deierhoj et al., 2013). Resistance to clindamycin is 20-

LEADING CAUSE OR CAUSES OF SURGICAL SITE INFECTION

52

60%; other antibiotics such as cefoxitine, cefotetan, and ampicillin/ sulbactam also are showing
resistance. This makes targeting oral antibiotics to the surgery type and bacteria expected to reduce SSI
very problematic (Deierhoj et al., 2013).
Figure 10 shows the 2017 recommendations for prophylactic antibiotics listed in JAMA.
Figure 10 Antibiotic Recommendations
1A.1. Administer preoperative antimicrobial agents only when indicated based on published clinical practice
guidelines and timed such that a bactericidal concentration of the agents is established in the serum and tissues
when the incision is made. (Category IB–strong recommendation; accepted practice.)
1A.2. No further refinement of timing can be made for preoperative antimicrobial agents based on clinical
outcomes. (No recommendation/ unresolved issue.)
1B. Administer the appropriate parenteral prophylactic antimicrobial agents before skin incision in all cesarean
section procedures. (Category IA–strong recommendation; high-quality evidence.)
1C. The literature search did not identify randomized controlled trials that evaluated the benefits and harms of
weight-adjusted parenteral antimicrobial prophylaxis dosing and its effect on the risk of SSI. Other
organizations have made recommendations based on observational and pharmacokinetic data, and a summary
of these recommendations can be found in the Other Guidelines section of the narrative summary for this
question (appendix 1 of the Supplement). (No recommendation/unresolved issue.)
1D. The search did not identify sufficient randomized controlled trial evidence to evaluate the benefits and
harms of intraoperative re- dosing of parenteral prophylactic antimicrobial agents for the prevention of SSI.
Other organizations have made recommendations based on observational and pharmacokinetic data, and a
summary of these recommendations can be found in the Other Guidelines section of the narrative summary for
this question (appendix 1 of the Supplement). (No recommendation/unresolved issue.)
1E. In clean and clean-contaminated procedures, do not administer additional prophylactic antimicrobial agent
doses after the surgical incision is closed in the operating room, even in the presence of a drain. (Category IA–
strong recommendation; high-quality evidence.)

(Berrios-Torres et al., 2017, p. 786)
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Comorbidities
The Charlson Comorbidity Index (CCI) considers the one-year mortality of internal medicine
inpatients (Khan, Muqim, Zarin, Khalil, & Salman, 2010). Charlson and his coworkers developed CCI in
1987 and it consisted of 19 items that are weighted and can be looked at retrospectively via chart
review (figure 11). Khan et.al. concluded as CCI and ASA increased so did SSI (Khan, Muqim, Zarin, Khalil,
& Salman, 2010).
Figure 11 Charleson Comorbidity Scores

(http://touchcalc.com/calculators/cci_js)

LEADING CAUSE OR CAUSES OF SURGICAL SITE INFECTION

54

Increases body mass index (BMI) has been associated with an risk of SSI in gynecologic surgeries.
It was found that SSI was as high as 8.9% in the morbidly obese compared to 1.4% in the normal weight
patient (Pellegrini et al., 2017).
Figure 7 Patient Level Risk Factors
Obesity
Diabetes mellitus
Smoking status
Steroid use
Nutritional status
American Society of Anesthesiologists Physical Status Health care provider-level risk
factors Adherence with hand-washing and use of proper surgical attire Surgical risk factors
Preoperative skin antisepsis
Preoperative hair removal
Operating room temperature
Type of surgery
Duration of surgery
Insertion of foreign material
Appropriate redosing of antibiotics (e.g., owing to prolonged duration of surgery, excessive
blood loss)
(Pellegrini et al., 2017)
Blood Transfusion
Blood transfusions have been associated with infections (Torgan, 2014). Torgan writes that
patients with fewer transfusions had a lower risk of infections. More than 37,000 units of RBCs are
transfused everyday in the United States. The risk of an infection related to the transfusion itself is very
rare because blood is screened for a number of items (Torgan, 2014). However, there may be an
immune response to stored blood or its components making the patient more susceptible to other
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infections. A study published in April of 2014, in JAMA, showed an infection rate of 17% when liberal
transfusion procedures are utilized versus 12% when a restrictive program is utilized (Torgan, 2014).
Patients with HCT levels that are tolerable and not causing other issues with health may see more harm
than benefit from a blood transfusion (Torgan, 2014).

New Trends

Recently copper infused surfaces and linens have gained popularity. Copper has been used for
centuries as a bacteriocidal (Lazary et al., 2014). The effects of copper on bacteria, fungi and viruses has
been shown in many studies (Lazary et al., 2014). Borkow et.al. writes the most common types of
nosocomial infections include staphylococci, pseudomonas, and E Coli (Borkow & Gabbay, 2008). In the
United States, approximately two million patients contract an infection while being treated for other
issues. Nosocomial infections are the fourth leading cause of death in the United States, many which
are resistant to antibiotics (Borkow & Gabbay, 2008). MRSA has increased from less than 5% in the
1970s to the present, and is as high as 40% in some facilities. Many are transferred via direct contact
often because of unwashed provider hands (Borkow & Gabbay, 2008). Textiles are excellent reservoirs
for infection if the correct temperature and moisture content are present. High bacteria counts occur
on the skin, nasal cavities, and the genital areas (Borkow & Gabbay, 2008). The act of changing sheets
can spread these bacteria. As the linens are being moved the subsequent bacterial load in the air may
be up to 6,000 CFU/mc (Borkow & Gabbay, 2008). These bacteria can spread to the halls where CFUs
can be two times higher than normal. Up to 21% of nosocomial, infections occur from contaminated
surfaces. Borkow et.al. performed a pilot study of 30 patients using copper infused linens. They found
significantly less CFUs on the biocidal linens (Borkow & Gabbay, 2008).
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Copper is toxic to microorganisms via several non-parallel paths. These involve damage to
microorganisms, enveloping bacterium, damage to intracellular proteins and nucleic acids (Lazary et al.,
2014). The bacteria, viruses and fungi have processes to handle excessive copper concentrations.
However, there is a threshold when these processes become overwhelmed and the organism dies
(Lazary et al., 2014). Even though bacteria have become resistant to antibiotics over the past fifty years’
resistance to copper is very rare. Copper has had many uses in health care to date such as control of
Legionella in hospital water systems, reduction of dental cavities, lowering of food borne diseases and
birth control (Lazary et al., 2014). Recently the use of copper has been extended to surfaces and linens
in hospitals to decrease the bioburden. The EPA has approved the use of copper in hospitals; it is
currently the only metal that kills 99.9% of gram positive and negative organisms (Lazary et al., 2014).
According to the authors recent technology allows copper oxide into polymeric material, making them
anti-microbial/viral, and possibly helpful in wound healing. Copper oxide is non- soluble and therefore
will not wash out of the linens for the life of their use. There are no documented reactions to the linens
at the time of this study (Lazary et al., 2014). Lazary et.al. wanted to study and prove these linens did
decrease HAIs. The results showed a 24% reduction in HAIs. In addition, the number of days with fever
was reduced and fewer antibiotics were used. The facility also recognized a 24% cost savings over
patients using normal sheets (Lazary et al., 2014).
Sifri et.al. write hospital environments play a big role in patients acquiring HAIs (Sifri, Burke, &
Enfield, 2016). Many organisms such as MRSA, Vancomycin resistant Enterococcus (VRE), extendedspectrum β - lactamase producing Enterobacteriaceae (ESBC), multi-drug resistant Acinetobactericaea
spp, and carbapenem – resistant Enterobacteriacaea (CRE) can live on surfaces for extended time and
thereby increase the risk of infection transmission (Sifri, Burke, & Enfield, 2016). Additionally, the spore
forming Clostridium difficile can survive months on objects (Sifri, Burke, & Enfield, 2016). This is
significant because studies have shown only 25-50% of hospital surfaces are not cleaned routinely (Sifri,
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Burke, & Enfield, 2016). Even the use of non-touch cleaning techniques have had minimal results,
require the room to be empty, and special training of housekeeping staff (Sifri, Burke, & Enfield, 2016).
Recently, self-disinfecting surfaces have been introduced to hospitals. The authors used real world
testing when a 1970s era wing was upgraded using copper composite hard surfaces and linens. The
countertops, sinks, vanities, patient room desks, computer stations, soiled utility room and nurses’
stations were all copper impregnated. The molded composite surfaces such as bed rails and bedside
tables were copper impregnated. Linens included patient gowns, towels, pillowcases, fitted and flat
sheets, washcloths, bath blankets, and thermal blankets. The results were 78% less HAIs due to MDRO
or C. difficile (Sifri, Burke, & Enfield, 2016).

Conclusion

While many studies have been performed and preventative measures taken to prevent infection
after surgery over the years, SSI remains a pervasive problem in the United States today. It is associated
with increased mortality and cost. Monitoring remains problematic. Additionally, there are many
studies examining risk factors, some which can be influenced by changes in practice or behavior. Many
of the study results are contradictory. It is the aim of this study to use a large US representative sample
of individuals hospitalized for abdominal surgery to examine risk factors and combinations of risk factors
associated with SSI and to delineate any changes in these factors over a ten-year period.
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CHAPTER 3 METHODS
Problem statement: What are the leading risk factors of surgical site infection after abdominal
surgery over ten years (2004-2014).

Hypothesis: Many risk factors for SSI will change over the ten-year study time period.

This is a retrospective study using a ten-year national sample of data from the Health Care
Utilization and Cost Project data (HCUP) ("HCUP Database," 2017). The HCUP national sample is a
representative sample of 10% of all hospital bills for all states across the United States from all payers.
The cohort includes all individuals hospitalized for abdominal surgery. Risk factors will be compared
between those who develop SSIs and those who do not and will be followed for changes over time
("HCUP Database," 2017).
Defining the Inception Cohort
The initial data collection will be completed using the International classification of diseases
codes, (ICD-9 codes). Codes and procedures to define the abdominal surgery cohort will include the
following: 43.0-43.9 operations of the digestive system incision/excision of the stomach. Endoscopic
surgeries are not intra-abdominal and therefor will be excluded. Trauma surgeries on the abdomen are
inherently “dirty” and are therefore also excluded. All other general surgeries on the abdomen open
and laparoscopic are included in the data collection. Obstetrical and gynecologic surgeries are also
excluded. All inclusion and exclusion codes can be found in Table 5.
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Table 5: Coding of Indicator Variables for Abdominal Surgery Cohort
Indicator Variable
(exclusion criteria)
Stomach
(exclusion)

Intestines
(exclusion)

Appendix
Rectum

Liver

(exclusion)

Gallbladder
(exclusion)

ICD-9 Procedure Description
Incision and excision of stomach
Other operations of the stomach
Endoscopic excision or destruction of lesion or tissue of
stomach
Closed [endoscopic] biopsy of stomach
Incision/excision and anastomosis of intestines
Other operations of the intestines
Diagnostic (endoscopic) procedures on the large intestines
Endoscopic excision or destruction of lesion of duodenum
Endoscopic polypectomy of large intestine
Endoscopic destruction of other lesion or tissue of large
intestine
Endoscopic placement of stent
Transplant of intestine
Operations on appendix
Abdominoperineal resection of rectum
Anterior resection of rectum with synchronous colostomy
Other anterior resection of rectum
Hepatotomy
Diagnostic procedures on liver
Local excision or destruction of liver tissue or lesion
Lobectomy of liver
Hepatectomy
Repair of the liver
Other operations on the liver
Transjugular biopsy
Liver transplant
Closure of laceration of the live
Extracorporeal assistance
Local perfusion of the liver
Operations on gallbladder and biliary tract
Endoscopic retrograde cholangiopancreatography
Endoscopic retrograde cholangiography
Percutaneous biopsy of gallbladder or bile ducts
Other closed [endoscopic] biopsy of biliary duct or
sphincter of Oddi
Other diagnostic procedures on biliary tract
Endoscopic dilation of ampulla and biliary duct
Endoscopic sphincterotomy and papillotomy
Endoscopic insertion of nasobiliary drainage tube
Endoscopic insertion of stent (tube) into bile duct
Endoscopic removal of stone(s) from biliary tract

ICD – 9
Procedure Codes
43.xx
44.xx
43.41
44.14
45.xx
46.xx
45.2x
45.30
45.42
45.43
46.86
46.97
47.xx
48.5x
48.62
48.63
50.0x
50.1x
50.2x
50.3x
50.4x
50.61
50.9x
50.13
50.5x
50.6x
50.92
50.93
51.xx
51.10
51.11
51.12
51.14
51.15
51.19
51.84
51.85
51.86
51.87
51.88
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Pancreas
(exclusion)

Hernia
(exclusion)
Other_ab

(exclusion)

Operations on pancreas
Transplant of pancreas
Closed [aspiration needle percutaneous] biopsy of pancreas
Endoscopic retrograde pancreatography
Closed [endoscopic] biopsy of pancreatic duct
Endoscopic excision or destruction of lesion or tissue of
pancreatic duct
Endoscopic insertion of stent (tube) into pancreatic duct
Endoscopic removal of stone(s) from pancreatic duct
Endoscopic insertion of nasopancreatic drainage tube
Endoscopic dilation of pancreatic duct
Repair of hernia
Unilateral repair of femoral hernia
Bilateral repair of femoral hernia
Other operations on abdominal region
Other repair of abdominal wall and peritoneum
Other repair of abdominal region
Diagnostic procedures of abdominal region
Excision or destruction of lesion or tissue of abdominal wall
or umbilicus

61
52.xx
52.8x
52.11
52.13
52.14
52.21
52.93
52.94
52.97
52.98
53.xx
53.2x
53.3x
54.xx
54.7x
54.9x
54.2x
54.3x

Defining the Outcome – SSI
Individuals within the abdominal surgery cohort who have indication of codes indicative
of SSIs similar to those used in other studies will be compared to patients with no indication of these
codes. SSI codes include 998.59. Those with SSIs will be further categorized as deep versus superficial
using the following definitions: the CDC defines SSI as an infection where depth and tissue spaces are
involved. Superficial infection includes the skin and subcutaneous tissue. A deep incisional SSI includes
the fascia and muscle layers and finally, an organ space SSI involves any part of the body opened or
manipulated during a procedure excluding the other types of SSI previously mentioned (Ban et al., 2017,
Pear, 2007).
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Defining Risk Factors
Covariates of interest were coded to test the change in surgical site infection among some
subgroups of patients. The HCUP SID was utilized to identify patients who underwent bariatric surgery,
utilizing ICD-9 procedure codes for bariatric surgery indicator variable which include 43.82 (laparoscopic
sleeve gastrectomy), 48.39 (open sleeve gastrectomy), 44.31 (high gastric bypass/ verticle banded
gastroplasty) 44.38 (laparoscopic gastroenterostomy), 44.39 (gastric bypass), 44.68 (laparoscopic
gastroplasty/vertical band), and 44.95 (laparoscopic gastric restrictive procedure/LAGB). ICD – 9
diagnosis codes for obesity and morbid obesity indicator variables were used to identify the risk factor
for obesity, which include 278,00 (morbid obesity) and V85.4x (body mass index 40 and over) (Johnson,
Simpson, Harvey, & Simpson, 2016). Bariatric surgery and obesity are of particular interest. In recent
years obesity rates have increased and so has use of bariatric surgery (Johnson et al., 2016). We are
interested to see if there is a correlation between these variables and SSI. We will exam age in a
continuous as well as by dichotomous groups (age over 65 and age less than 65). As mentioned earlier
in this paper Kaye et.al published a study in 2005 showing an increase in SSI up to age 65 and the SSI
decreased in those greater than age 65 (Kaye et al., 2005).
The CDC has published maps showing obesity and diabetes trends. The authors are very
interested in how this correlates with the prevalence of SSI. As is evident by these maps obesity and
diabetes are an increasing and potentially serious health care problem ("CDC Diabetes and Obesity
Database," 2017).
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("CDC Diabetes and Obesity Database," 2017)
The following data points will be utilized to define the descriptive and the risk factors of patients
with SSI: Age, age group, admission schedule/unscheduled, admission year, pints of blood administered,
chronic condition body system, chronic condition indicators, AHRQ comorbidities (AIDS, Alcohol abuse,
deficiency anemias, CHF, COPD, diabetes uncomplicated, diabetes with chronic complications, drug
abuse (yes no), hypertension, liver disease, obesity), days in the ICU, length of stay, median income by
zip code, patient state/county code, race, readmission and total charges ("HCUP Database," 2017).
Please see Table 6.
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Table 6 HCUP Risk Factor Variable and descriptors

Age
AHOUR
Agegroup
ASCHED

Field

Data Type
Number
Number
Number
Character

Value

AYEAR
Blood

Number
Number

0 unscheduled 1
scheduled
YYYY
0-999.99

Chronic

Condition

Database

DaysICU
LOS
ZIPINC_QTRL

Number
Number
Character

HOSPSTCO

Number

0-999
0-365
1 – 1 to 38,999 2 –
39,000 to 47,999, 3 –
48,000 to 62,999, 4
63,000 and above
5n

RACE

Character

TOTCHG
Sex

Number
Character

0-124
HHMM

1 – white, 2 – black, 3 –
Hispanic, 4 – Asian pac
isl, 5 – native American,
6 – other
Dollars
0 – male 1 – female

Description
Age in Years
Time of admission
Ranges
Admission
scheduled/unscheduled
Admission year
Pints of blood
administered
Chronic condition
system
Chronic condition
indicator
AHRQ comorbidities
(Aids,ETOH,deficiency
anemia, COPD, DM
uncomplicated/chronic
complicated, drug
abuse yes/no, HTN, and
Liver Dx
Days in ICU
Length of stay
Median income code

Patient state/county
code
Race

Total charges
Sex

(.) = missing data (.A) = invalid data (.B) = data unavailable (.C) = inconsistent data
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Statistical Methods

Descriptive statistics will be calculated on the total cohort and on each group, those patients
with and without SSI. Each of the variables listed in the risk factors section above will be included in a
descriptive table where continuous variables will be summarized using mean and standard deviation and
categorical variables will be summarized using frequency counts and percentages. Total cost for those
with and without SSI will be included in the descriptive table in bivariate analysis only.
In order to examine risk differences between patients who have undergone abdominal surgeries
we will use multivariable logistic regression to model the dependent variable of whether or not their
surgery resulted in an SSI or not. All risk factors listed in the above section will be entered into the
model as independent variables, first one at a time in a series of simple logistic regression models. Then
we will perform model fitting using all the potential risk factors to examine their independent statistical
significance. Lastly, we will add a year variable to the model to estimate if overall risk of SSI changes
over the study time period and then we will examine if each of the risk factors vary by year by testing
their interaction with the time variable. Model fitting procedures of “purposeful selection” will be used
as recommended in the textbook “Applied Logistic Regression” by Hosmer and Lemeshow.
SAS (Cary, NC) statistical software Version 9.4 will be used to perform all analysis and factors will
be considered statistically significant if the p-value falls below an alpha level of 0.05. The Institutional
Review Board (IRB) at the Medical University of South Carolina has deemed all research using these deidentified HCUP datasets to be non-human and therefore the study does not require IRB approval.
LIMITATIONS
There have been many other risk factors of increased SSI that have been studied previously
which cannot be included in this study due to limitations in the availability of those variables in the
study data source. Although copper impregnated sheets and surfaces show promising decreases in SSI

LEADING CAUSE OR CAUSES OF SURGICAL SITE INFECTION

66

this data cannot be evaluated in this study. The use of preoperative antibiotics and their timing is not
included in the HCUP database and thus will not be examined. Treatments such as glucose control,
bowel preparation, prophylactic antibiotics from home, preoperative bathing and clipping of hair are not
available for inclusion. Facility factors that cannot be tested or controlled for are the type of air flow,
surgical preparations used, hand washing techniques and surgical technique.
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Chapter 4 Results
Overall 6,981,183 patients were identified as having had abdominal surgeries during the study period,
(Table 7) which included 6,825, 886 patients without SSI and 155,297 with SSI. The average age for both
groups was similar for both groups at admission 55.25 (21.33) vs. 55.72 (19.23) no SSI vs. SSI
respectively. The Charlson Comorbidity scores and the number of chronic conditions were also similar
between the groups see table x. Even though length of stay (LOS) is not a risk factor for SSI it is
interesting to note that the average LOS for SSI was 17.47 (20.75) days whereas the LOS for NO SSI was
7.4 (11.4) days. This coincides with the significantly higher cost associated with SSI versus no SSI
$45,358.49 (62,987.69) versus $19,253 (32,526.27).

Table 7 Descriptive Statistics of Demographic Characteristics and Risk Factors
No SSI
SSI
(n =6,825,886)
(n=155,297)
Mean (std dev)
Mean (std dev)
Age at Admission (years)
55.25 (21.33)
55.72 (19.23)
Length of Stay (Days)
7.40 (11.40)
17.47 (20.75)
Total Cost ($)
19,253.28 (32,526.27)
45,358.49 (62,987.69)
Charlson Comorbidity Score
1.43 (2.28)
1.45 (2.38)
Number of chronic
4.63 (3.32)
4.47 (3.14)
conditions
N (%)
N (%)
Type of Abdominal Surgery
Stomach Surgery
1158249 (16.97%)
18,447 (11.88%)
Intestinal Surgery
2943992 (43.13%)
67968 (43.77%)
Appendix Surgery
760901 (11.15%)
10693 (6.89%)
Rectum Surgery
28191 (0.41%)
1894 (1.22%)
Liver Surgery
269315 (3.95%)
5700 (3.67)
Gallbladder Surgery
885620 (12.97%)
9912 (6.38%)
Pancreas Surgery
49879 (0.73%)
3574 (2.3%)
Hernia Surgery
581977 (8.53%)
13194 (8.5%)
Other Abdominal Surgery
1624776 (23.8%)
102047 (65.71%)
Female
Died
Elective Surgery
Gastric Surgery
Obese
Race

3,826447 (56.25%)
204,158 (2.99)
1,925,061 (28.29%)
86329 (1.26%)
341566 (5.0%)

81,957 (52.80%)
7,152 (4.61)
46,382 (29.95%)
2677 (1.72%)
8325 (5.36%)
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White
3922760 (68.45%)
94497 (71.89%)
Black
759943 (13.26%)
15185 (11.55%)
Hispanic
702428 (12.26%)
14181 (10.79%)
Asian Pacific
138747 (2.42%)
2965 (2.26%)
Native American
35488 (0.62%)
899 (0.68%)
Other
171810 (3.0%)
3727 (2.84%)
Zip Income Qrtl ($)
1-38,999
1844018 (27.64%)
39144 (25.8%)
39,000-47,999
1734379 (26.00%)
39120 (25.79%)
48,000-62,999
1627009 (24.39%)
38033 (25.07%)
63,000 and above
1465539 (21.97%)
35419 (23.35%)
Hospital Region
Northeast
578939 (20.03%)
13632 (21.57%)
Midwest
651551 (22.55%)
14361 (22.72%)
South
1056074 (36.54%)
21724 (34.37%)
West
603312 (20.88%)
13492 (21.35%)
Hospital Bed Size
Small
240408 (13.94%)
4469 (11.80%)
Medium
469776 (27.23%)
9539 (25.20%)
Large
1014962 (58.83%)
23849 (63.00%)
Location teaching status
Rural
141287 (8.19%)
2283 (6.03%)
Urban Non Teaching
579936 (33.62%)
9933 (26.24%)
Urban Teaching
1003923 (58.19%)
25641 (67.73%)
Primary Payer
Medicare
279876 (41.10%)
62884 (40.57%)
Medicaid
886461 (13.01%)
19287 (12.44%)
Private insurance
2477090 (36.36%)
60190 (38.83%)
Self-pay
389849 (5.72%)
6474 (4.18%)
No charge
41512 (0.61%)
897 (0.58%)
Other
217634 (3.19%)
5271 (3.40%)
Hospital Ownership
Government, nonfederal
203,664 (11.81%)
4,936 (13.04%)
Private, not-for-profit
1,270,875 (73.67%)
28,791 (76.05%)
Private, investor owned
250,607 (14.53%)
4,130 (10.91%)
*Values are reported as Mean (Std Dev) for continuous variables and N (%) for categorical variables.

Logistic regression analysis showed significance differences in risk of SSI for many risk factors.
The predictors included in the final risk prediction model due to significance and model fit
characteristics included: age, gender, race, Charlson Comorbidity Score, whether or not the surgery was
elective, obesity diagnosis, whether or not the surgery was for gastric bypass, type of payer, income
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quartile, year and surgery types: stomach, intestines, appendix, rectum, liver gallbladder, pancreas, and
other abdominal surgery (p-values all <0.0001).
Multivariable Logistic log-odd estimates and risk factor p-values are reported in Table 8. The
data shows females are less likely to develop a surgical site infection than males. Being Black carries a
lower risk than being White in contracting SSI. Surprisingly is that the higher the Charleson score the
less likely the patient was to develop a SSI. As expected elective surgery carries a lower risk of SSI than
non-elective surgery. Those patients covered by Medicare were at a higher risk than all other payers.
As Figure 11cshows the risk of SSI in general has decreased over the last 10 years. See Table 8 for all
likelihood estimates.
Table 8 Likelihood Estimates of Developing a SSI
Analysis of Maximum Likelihood Estimates
Parameter
Intercept

DF
1

Estimate
12.7329

Standard Error
1.7274

Wald Chi-Square
54.3307

PR>ChiSq
<.001

Age

1

.00220

0.000182

146.2049

<.001

Female

1

-0.2499

0.00542

2128.4564

<.001

Race

White

1

0.1053

0.00409

662.7251

<.001

Race

Black

1

-0.1237

0.00606

416.3084

<.001

CharlsScore

1

-0.0683

0.00124

3037.4818

<.001

Elective

1

-0.2331

0.00605

1482.8309

<.001

Obese

1

0.1218

0.0118

106.6530

<.001

Gastric_surgery

1

0.1762

0.0206

72.9789

<.001

Payer

Medicaid

1

-0.00823

0.00666

1.5277

0.2165

Payer

Medicare

1

0.0187

0.00571

10.7902

0.0010

Payer

Other

1

-0.0920

0.00742

153.9999

<.001

Zipinc_qrtl

1-38,999

1

-0.0384

0.00465

68.2987

<.001

Zipinc_qrtl

39,000-47,999

1

-0.00568

0.00453

1.5702

0.2102

ZipincQtrl

48,000-62,999

1

0.0157

0.00458

11.7782

0.0006
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Stomach

1

0.1687

0.00846

397.9648

<.001

Intestines

1

0.5547

0.00579

9164.2871

<.001

Appendix

1

-0.0321

0.0109

8.6719

0.0032

Rectum

1

1.4252

0.0258

3061.7907

<.001

Liver

1

0.3307

0.0145

522.2475

<.001

Gall

1

-0.2580

0.0111

541.1865

<.001

Pancreas

1

1.3547

0.0190

5078.8379

<.001

Other_ab

1

2.0731

0.00610

115396.264

<.001

Year

1

-0.00877

0.000860

104.0191

<.001

% SSI Per Year
4
3.5
3
2.5
2

% SSI Per Year

1.5
1
0.5
0
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Figure 11: SSI infection rate per year over 10 years

In multivariable Logisitic regression results examining risk factors for SSI, odds ratios were
reported for each predictor variable. Age increased the risk significantly. For every year of age the risk
increased by 0.2%. Over ten years this represents a 2% higher risk of a SSI. Being female was associated
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with a 22.1% less likelihood of developing a SSI. Interestingly as the Charlson Score increased the
likelihood of developing a SSI was 6.6% less. Patients who are obese had a 13% higher risk of developing
a SSI, and having a gastric surgery was associated with a 19.3% higher risk. As expected having rectal
surgery had 4.159 higher odds of developing a SSI. Other high risk surgeries and developing a SSI were
liver surgery, 1.392 higher odds, pancreas surgery 3.876 higher odds and other abdominal surgeries had
a 7.950 higher odds than all other types of abdominal surgeries. Surgery category “Other abdominal
surgeries” included ICD 9 codes 54.xx other operations of the abdominal region, 54.7x other repair of
the abdominal wall and peritoneum and 54.9x other repair of the abdominal region. See table 9 Odds
ratios.
Table 9 Odds Ratio Estimates
Odds Ratio Estimates
Effect

Point Estimate

95% Wald Confidence Limits

Age

1.002

1.002

1.003

Female

0.779

0.771

0.787

White Vs. Other

1.091

1.078

1.104

Black Vs. Other

0.868

0.851

0.885

CharlsScore

0.934

0.932

0.936

Elective Surgery

0.792

0.783

0.802

Obese

1.130

1.104

1.156

Gastric Surgery

1.193

1.145

1.242

Medicaid vs. Private payer

0.914

0.898

0.930

Medicare vs. Private payer

0.939

0.926

0.953

Other vs. Private payer

0.841

0.824

0.858

$1-38,999 vs. $63,000 and above

0.935

0.921

0.950

$39,000-47,999 vs. $63,000 and above

0.967

0.952

0.981
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$48,000-62,999 vs. $63,000 and above

0.987

0.973

1.002

Stomach

1.184

1.164

1.204

Intestines

1.741

1.722

1.761

Appendix

0.968

0.948

0.989

Rectum

4.159

3.954

4.374

Liver

1.392

1.353

1.432

Gall

0.773

0.756

0.790

Pancreas

3.876

3.734

4.023

Other Abdominal Surgery

7.950

7.855

8.045

Year (2004-2014; 1yr increments)

0.991

0.990

0.993
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Significant interaction effects were found between the following variables by year; age group,
race, gender, payer, obesity, and gastric, intestinal, stomach, other abdominal and appendix surgeries.
Significant predictors of SSI that show an interaction over time are illustrated using line graphs. The first
is within the 10-year age groups (p-value < 0.0001). This is seen in Fgure 12, risk was highest in the age
year group 60-69 consistently across the 10 years. Those in the age group 80 and above had the lowest
risk across all years.
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Figure 12 Age Group vs. SSI Over Time
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There were significant interactions between SSI and payer type as well (p-value <0.0001). For all
considered years individuals with private insurance were consistently among those with the higher risk
for SSI. Those in the other payer group (no charge, self pay, and all other payers) had the lowest risk of
SSI. This can be seen in Figure 13 below.
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Figure 13 SSI Rate by Payer Over Time
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Significant interactions were seen between race and SSI over time (p-value <0.0001, Figure 14).
White patients had the highest rate of SSI over time and Black patients had the lowest rate over time,
with “other” race individuals falling just above or at similar risk to Black patients. This is consistent with
a study performed by Wiseman et.al. in 2015. They also found being black was protective for SSI

(Wiseman et al., 2015).
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Figure 14 SSI Rates by Race Over Time
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A significant interaction between male and female genders over time (p-value <0.0001) was
seen as shown in figure 15. Males were found to have a higher risk of SSI than females over each year.
However, these rates became much closer from 2011 to 2014. This may be attributed to less surgery in
males or more use of laparoscopic surgery.
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The interaction between appendix surgeries and all other types of abdominal surgeries was
significant by year (p-value <0.0001). The rate of SSI associated with appendix surgeries was lower than
that all other types of abdominal, however the rate was greater from 2007 until 2011 and low in the
years prior to 2007 and the years after 2011 (Figure 16).
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Appendix

Figure 16 SSI Rates by Year Appendix Surgery vs. All Other Types of Surgeries Not Included In Other Surgeries
Over Time
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Significant interactions were found between Intestinal surgeries and all other types of surgeries
(p-value <0.0001) as seen in Figure 17. The risk of SSI in intestinal surgery was higher than all other
surgeries from 2004 until 2011 when all other types surgeries began to have more equal or slightly
higher risk of SSI.
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Intestinal Surgery

Figure 17 SSI Rates Per Year Intestinal Surgery vs. All Other Types of Surgeries Not included In Other Surgeries
Over Time
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Significant interactions were seen between stomach surgeries and all other surgeries over time
(p-value <0.0001, Figure 18). Stomach surgeries consistently had lower rates of SSI than all other
surgeries over time.
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Figure 18 Stomach Surgeries vs. All Other Surgeries Not Included In Other Surgeries Over Time
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Other abdominal surgeries had significantly higher rates of SSI than the surgeries not included in
this category (p-value <.001) Figure 19. Other surgeries included other operations on the abdominal
region, other repair of the abdominal wall and peritoneum and other repair of the abdominal region. In
2009 the trend for SSI in this region showed consistent decline.
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All Other Surgeries Not in the Other Surgeries Category
Other Abdominal Surgeries
Figure 19 Other Abdominal Surgeries vs. All Other Abdominal Surgeries over Time
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Obesity and non obese showed significant interactions with SSI over time (p-value <0.0001,
Figure 20). During the years 2004 to 2008 non-obese patients had a higher risk of developing a SSI than
those with a ICD 9 diagnosis of being obese. In 2009 those diagnosed as obese began having rates of SSI
higher than those considered non-obese. The trend, even though greater than non-obese has
decreased from 2009 until 2014. However, obesity is likely an ICD code that is under coded and coding
practices for this diagnosis may have changed over time based on the new ICD-10 codes being more
specific.
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Figure 20 SSI Rates in Obese vs. Non Obese by Year Over Time
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Significant interactions were also found between gastric surgeries and all other surgeries per
year as seen in (p-value=0.0024), Figure 21. Risk of SSI is consistently higher than non-gastric surgeries
every year data was available (2006 to 2014). However, in 2011 the rate decreases significantly.
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Figure 21 SSI Rates Per Year Gastric Surgery vs. Non-gastric Surgeries
*There are not enough data points to report for Gastric Surgeries in years 2004 and 2005
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Chapter 5 Discussion
The purpose of this study was to determine if there was a trend in abdominal surgeries
and SSIs and whether those trends have changed over time. There have been many studies over the
years trying to determine a cause for SSI and whether there interventions that can decrease the risk(s)
of having a SSI. This study has shown the rate of SSI has been decreasing since 2009. This is an
encouraging statistic however, there are real costs associated with SSI. This study has shown that the
LOS for no SSI was 7.4 days compared to 17.47 days for those with SSI. This represents nearly double
the time in the hospital. The cost associated with SSI remains a problem as well. The cost for no SSI was
found to be $19,253 while those with SSI $45,358, a nearly 2.5 times the cost. This is consistent with
many other studies such as those by Schweitzer (Ban et al., 2017, Pellegrini et al., 2017, Schweizer,
Cullen, Perencevich, & Vaughan Sarrazin, 2014). We found an overall decreasing risk in SSI since 2009.
It might be reasonable to assume this is the result of an increase in laparoscopic surgeries. What are we
as health care providers doing that is causing SSI to decrease since 2011? Can we discover why and
continue the trend and stop or minimize those things we are doing that cause SSI?
Walraven et al created a SSI risk score. Pear also created an index looking at differing
facilities with differing levels of comorbidity (Pear, 2007, Walraven & Musselman, 2013). These studies
found as the number of coexisting diseases increased so did the risk of SSI. We found that as the
Charlson score increased the rate of SSI decreased. This may be significant because it takes into account
all hospitals across the country whether they are small community or large teaching hospitals, trauma
centers or non-trauma, private as well as public.
Previous studies have focused on surveillance and how poor it is (Anderson and pear
references). Under reporting for our study may be a confounding factor. There was no way to capture
superficial infections just as in other studies. Superficial infections treated at the doctor’s office were
not included in this study.
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Previous studies such as those by Kaye et al, McGarry et.al. and Khan et.al. have all
looked at age and SSI. The findings ranged from no effect due to age to older patients are more likely to
have increased LOS, costs and infections (Kaye et al., 2005, Khan, Muqim, Zarin, Khalil, & Salman, 2010).
We found age was a significant risk factor over time. The oldest age group, 80+ years, had the lowest
risk of developing an SSI. Age groups 18-29 had the next lowest risk, followed by 30 – 39. Age 70 – 79
had the third highest rate of SSI. Age 50 – 59 and 60 -69 had nearly the same risk and was the highest of
all the age groups.
We found that the type of surgery and if the patient was obese or not played a significant role in
developing a SSI. Rectal surgeries had one of the highest SSI rates when compared to all other surgeries
over time. Intestinal surgeries were very close to the rate of other surgeries over time. Surprising to the
authors was that the Charlson score had a negative predictor value and stomach and appendix surgeries
carried lower risk when compared to all other surgeries. Being male and white increased the risk of
developing a SSI. Being obese was a positive predictor and those patients had higher rates of SSI. It
would be reasonable to assume as the BMI increases throughout the country that the number of
patients developing SSI will also increase. Additionally the rate of SSI in those considered obese was
found to be higher than the overall rate of SSI for all types of abdominal surgery. Therefore it is
reasonable to assume the number of gastric surgeries will continue to increase as the rate of obesity
increases.
Based upon the literature review and this study it is easy to see SSI has a multifactorial cause. It
would be nearly impossible to control for and standardize all the factors involved. There have been
many different guidelines published by many organizations in an effort to reduce SSI. There is no
consensus on these guidelines and therefore can not be controlled for in studies. Each hospital has
different infrastructure, which cannot be controlled. Patient factors that can vary from facility to facility
as well as surgeon to surgeon in the same facility are preoperative bathing, hand washing of the care
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givers, surgical attire, personal belongings in the operating suite, pre existing conditions, blood sugar
control, smoking, temperature regulation of the patient, the use of bowel preparations, and pre
operative antibiotics both intravenous and oral. These factors can significantly affect the likelihood of
developing a SSI.
This study has shown there are significant trends over time. One promising area is age over
time. The age groups 40-49 and 50-59 have the highest rate of SSI over time. Facilities might want to
concentrate on these age groups in decreasing SSI. This may be related to the payer over time. These
two age groups are the most likely to have insurance coverage and therefore may be inferred, more apt
to utilize the health care system. This study found that private payers had the highest rate of SSI, which
may be these two age groups. Bringing down the rate of SSI in this group may decrease the overall rate
of SSI.
Future studies should use ICD 10 codes as they are more specific. For example in the case of
obesity ICD 10 codes may be more sensitive and prevent under coding. Pancreatic, rectal and other
abdominal surgeries have the highest rate of SSI. Future studies may need to focus on these areas to
see if the rate of SSI can be reduced. There are some treatments being tried such as enhanced recovery
after surgery (ERAS). This has shown some promise in reducing SSI and LOS. Future studies should also
include electronic medical record data. The data included may be anesthesia type, length of surgery,
intraoperative and postoperative temperature management, fluids and/or blood products administered.
The preoperative assessment includes and therefor can be included in a study pre-existing chronic
conditions and ASA score.
The study has shown a decreasing trend in SSI since 2009. This may be due to the Deficit
Reduction Act of 2005. Section 5001 (c) identifies procedures and conditions as high cost. SSI was
identified as one of the ten high cost hospital conditions. The final rule for repayment identified SSI as
one for repayment modification ("Section 5001(c)," 2014). In addition to government reimbursement
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for SSI the rules regarding surgical time outs changed in 2009. The expanded surgical timeout procedure
was amended in 2005 however, in 2009 wrong site wrong patient errors were no longer reimbursed by
the government. These timeouts were much more inclusive and may have had an impact on SSI rates

("AHRQ Time Out," 2017).
SCIP measures may have to be changed to help reduce SSI. Just as measures were taken to
reduce intraoperative and postoperative cardiac events measures may need to be created to continue
the reduction in SSI. Some examples may need to be researched further with ERAS procedures. These
may include prophylactic mechanical bowel preparations and the addition of high carbohydrate
supplements prior to surgery. Studies involving the use of different suture materials and dressings
gastric surgeries, rectal surgeries, pancreatic surgeries and those included in other abdominal surgeries
may be beneficial in the effort to continue reducing SSI.
Since our study may have under reported obesity this may be an area for further study. If
obesity turns out to be more predictive than we found SCIP measures could be created to decrease this
risk. These patients could have tight glucose control and diet modification prior to surgery to optimize
them from having an infection and to promote rapid wound healing. In our study data was not available
from 2004 – 2006 for gastric surgery. This is an indication to the author that obesity and gastric
surgeries may have been under-coded.
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